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ABSTRACT
Protein Phosphatase 2A Suppresses Spindle Elongation in Saccharomyces Cerevisiae
by
Shoily Khondker
Advisor: Amy Ikui, PhD
Eukaryotic cell division is an essential process that is carried out by the cell cycle, a
tightly controlled process that has been extensively studied in the budding yeast Saccharomyces
cerevisiae. The cell cycle is driven by Cyclin Dependent Kinase (Cdk1) activity. Protein
phosphatase 2A-Cdc55 (PP2ACdc55) reverses Cdk1 phosphorylation events during late stages of
the cell cycle to ensure the correct order of events. This thesis presents evidence that the
anaphase inhibitor Pds1 is a PP2ACdc55 target. Pds1 binds to and inhibits separase (Esp1). Esp1
triggers sister chromatid segregation by cleaving the cohesin complex that holds the chromatids
together, and by promoting spindle elongation through a poorly understood mechanism. The
Pds1-Esp1 physical interaction is dependent on Cdk1 phosphorylation at the Pds1 C-terminus. In
addition to preventing Esp1 proteolytic activity, Pds1-Esp1 binding is also necessary for Esp1
accumulation in the nucleus. The findings presented in this study demonstrate that PP2ACdc55
directly dephosphorylates Pds1 at Cdk1 phosphorylation sites. Nuclear exclusion of PP2ACdc55
resulted in strengthened Pds1-Esp1 interaction and premature Pds1 nuclear accumulation.
Findings from this study also showed that exclusion of PP2ACdc55 resulted in accelerated spindle
elongation, and conversely, hypophosphorylated Pds1 was associated with unstable spindles.
Thus, these findings show novel evidence that Pds1 phosphorylation status is linked to spindle
elongation rate and stability. The significance of Pds1 phospho-regulation by PP2ACdc55 in stress
conditions is also examined. The Pds1-Esp1 interaction is crucial for maintaining genome
integrity, which can be compromised by genotoxic stress such as DNA replication stress. This
study shows that both nuclear and cytoplasmic PP2ACdc55 are involved in the cell cycle response
iv

to DNA replication stress. PP2A-dependent Pds1 dephosphorylation and spindle inhibition is
enhanced during replication stress. This study also examines the possibility that PP2ACdc55 acts
independently of known replication stress response pathways. Lastly, this thesis explores a role
for PP2ACdc55 in the cell’s response to a loss of DNA replication control, as well as a functional
interaction between PP2ACdc55 and the replication protein Cdc6. DNA re-replication triggers cell
cycle arrest, which is shown to be dependent on nuclear PP2ACdc55 function. In summary, this
study enhances the current understanding of how PP2ACdc55 controls cell cycle processes,
including anaphase spindle elongation and checkpoint responses to threats to genome stability.
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Chapter 1. Introduction
1.1 Cell cycle broad overview
Cell proliferation is essential for survival in all organisms. In eukaryotes, cell growth and
division are carried out by a tightly regulated process known as the cell cycle. During the cell
cycle, genetic material is replicated during S-phase (DNA Synthesis) to yield two identical
copies of DNA. The DNA copies are then partitioned equally into two daughter cells during Mphase (Mitosis) (1) (Figure 1.1A). S-phase and M-phase are separated by two gap phases (G1
and G2) (1). Checkpoint mechanisms ensure that cell cycle events occur in the correct order and
that genetic information is accurately divided (2). Loss of checkpoint mechanisms causes
genome instability, which is a hallmark of cancer in higher eukaryotes (3). Therefore, it is
imperative to study the molecular mechanisms of cell cycle control. Cell cycle checkpoints have
been extensively studied in the model organism Saccharomyces cerevisiae.

1.2 S. cerevisiae as a model system
S. cerevisiae, or budding yeast, is a single cell eukaryotic organism. S. cerevisiae live as
either haploid or diploid cells (4). Haploid cells have two opposing mating types: a and alpha.
Budding yeast is a frequently used model system for studying the cell cycle due to several
advantages. First, strain construction can be performed by mating haploid strains to obtain the
desired genetic combinations (4). A PCR-based method can also be used for strain construction.
For example, proteins can be tagged epitopes such as hemagglutinin (HA) or MYC through PCR
using plasmid templates that contain selectable markers (5). The resulting PCR products are then
transformed into yeast cells and integrated into the genomic DNA by homologous recombination
(6, 7). Second, the cell cycle can be arrested in G1 phase using mating pheromone, alpha-factor,
1

and then released. Through this block-and-release technique, cell cycle progression can be
monitored in synchronized cultures. Conditional mutants can also be used to reversibly arrest the
cell cycle at various stages. Another advantage of using S. cerevisiae is that the cell cycle profile
can be determined by observing bud status (8). At the G1/S phase transition, the mother cell
produces a bud that progressively grows throughout the cell cycle, eventually resulting in a
dumbbell shape in mitosis (Figure 1.1A) (8). Flow cytometry has also been used to monitor cell
cycle status by measuring DNA content (9).The final major advantage of using budding yeast as
a model system is that there are resources available for strains, plasmids and genome/protein
data. These resources include deletion libraries in both haploid and diploid cells (10). Plasmids
containing open reading frames (ORF) are also available (11). Strains with ORFs tagged with the
green fluorescent protein (GFP) sequence are also commercially available, allowing for the
visualization of proteins in live cells by microscopy (12). Lastly, the full yeast genome database
is available at yeastgenome.org. In conclusion, S. cerevisiae is one of the most genetically
tractable model systems.

1.3 Cdk1 activity and regulation
Many of the genes controlling the cell cycle were discovered when Hartwell et al.
performed a genetic screen to isolate temperature sensitive mutants with cell cycle defects in S.
cerevisiae. This screen yielded 148 mutants that were further categorized into 32 groups after
complementation analysis (13). The mutated genes were named cdc mutant for cell division
cycle. Cdc28 was one of the genes isolated in this screen and was identified as a cyclindependent kinase (CDK). CDKs are serine/threonine kinases that phosphorylate target proteins at
consensus motifs (S/TP) (14). CDK activity is the driving force for cell cycle progression in all
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eukaryotic organisms. Cdc28 is a conserved gene and has homologs in humans (Cdk1) and
Schizosaccharomyces pombe or fission yeast (Cdc2) (15). Cdc28 will be referred to as Cdk1 for
the remainder of this thesis.
Cdk1 is regulated by its cyclin binding partners, as well as by activating and inhibitory
proteins. Cdk1 associates with cyclins that both activate its kinase function, and determine its
phosphorylation substrates (16). Cyclins were first discovered in sea urchins as proteins that
oscillate in abundance throughout the cell cycle (17). Cyclins are categorized into subsets that
are specific to cell cycle phase. The G1 cyclins are Cln1-3, the S-phase cyclins are Clb5 and
Clb6, and the Mitotic cyclins are Clb1-4 (Figure 1.1A) (18). Cdk1 activity is regulated by three
mechanisms: cyclin transcription, cyclin degradation, and Cdk1 activators/inhibitors. Another
mechanism to control cell cycle progression is the reversal of phosphorylation events by Cdk1counteracting phosphatases. During late cell cycle, phosphate groups on Cdk1 substrates are
removed by two phosphatases: PP2ACdc55 and Cdc14 (Figure 1.1B). PP2ACdc55- and Cdc14dependent dephosphorylation maintains the correct order of events in the cell cycle by ensuring
that Cdk1 substrates are reset prior to the following cell cycle (19, 20).
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Figure 1.1. Overview of the Cell Cycle in S. cerevisiae (A) There are four cell cycle phases, G1, S,
G2 and M. Cell cycle stages can be determined by cell morphology: cells are un-budded during G1,
small-budded during S-phase, and dumbbell-shaped cells during mitosis. Cell cycle progression is
driven by Cdk1 associated with cyclins. Cln1-3 are G1 cyclins, Clb5 and Clb6 are S-phase cyclins and
Clb1-4 are mitotic cyclins. (B) Overview of Cdk1 and counteracting phosphatase activity throughout the
cell cycle. CDK activity is shown in blue. CDK-counteracting phosphatase activity is shown in red.
(Adapted from Uhlmann et al. Philos Trans R Soc Lond B Biol Sci. 2011.)
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1.3.1 Regulation of cyclin protein levels
Cyclins are categorized into subsets that are specific to the cell cycle phase they regulate.
G1 cyclins (Cln1-3) promote cell growth and bud emergence; S-phase cyclins (Clb5-6) are
necessary for DNA replication initiation and regulation; and Mitotic cyclins (Clb1-4) promote
mitotic entry and progression (18). Cyclin protein levels oscillate in an ordered manner, creating
peaks and valleys of cyclin abundance that are controlled by transcription and protein
degradation (21).
Cyclin transcription is regulated by transcriptional activators and inhibitors that bind to
promoter elements. The G1 cyclin Cln3 is transcribed in early G1 phase (18). The Cln3-Cdk1
complex phosphorylates the transcriptional inhibitor Whi5 during the G1/S transition, resulting
in Whi5 nuclear export (22, 23). In the nucleus, Whi5 binds and inhibits the SBF complex
(Swi4/Swi6 cell cycle box Binding Factor), which consists of the transcriptional activators Swi4
and Swi6 (22, 23). The SBF complex activates Cln1 and Cln2 transcription (24), Therefore, Cln1
and Cln2 transcription peaks during G1/S upon Whi5 nuclear export (24, 25). S-phase cyclin
(Clb5-6) transcription peaks during S phase, and is activated by the MPF complex, which
consists of transcription factors Swi6 and Mbp1 (26). The MPF complex binds to the Mlu1 cell
cycle box promoter element to activate Clb5-6 transcription (26). Mitotic cyclin (Clb1-4)
transcription is activated by the transcription factor Fhk2 and its binding partner Ndd1, which are
recruited to the promoter by the Mcm1 transcription factor (27, 28). Therefore, cyclin
transcription occurs in a cell-cycle dependent manner and contributes to cyclin oscillation.
Cyclin abundance is also controlled by protein degradation, which is triggered by
ubiquitination. Ubiquitination occurs through a cascade where E1 enzymes activate an ubiquitin
group in an ATP-dependent manner, E2 enzymes conjugate the ubiquitin group, and E3 enzymes
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ligate ubiquitin to the substrate (29). Ubiquitinated proteins are then degraded by the proteasome
(30). There are two E3 ubiquitin ligase complexes that regulate cyclin levels: SCF (Skp, Cullin,
F-box) and APC (Anaphase Promoting Complex). SCF consists of the core proteins Cdc53,
Skp1, and Hrt1 (31). The SCF target protein is determined by an F-box binding partner, such as
Cdc4 (31). SCFCdc4 (SCF coupled with F-box protein Cdc4) activity is one of several
mechanisms in S-phase that limits DNA replication to once per cell cycle. The APC contains at
least 11 components (Apc1, Apc2, Apc4, Apc5, Apc9, Apc11, Doc1, Cdc16, Cdc23, Cdc26,
Cdc27) (32-34). APC substrates are determined by its activator: either Cdc20 or Cdh1 (35).
APCCdc20 promotes mitotic progression, while APCCdh1 is active in late mitosis and facilitates
mitotic exit (35). APCCdc20 targets S-phase cycle Clb5 and anaphase inhibitor Pds1 to promote
mitotic progression (36). Mitotic cyclin Clb2 is partially degraded by APCCdc20 in mitosis, and
then later fully degraded by APCCdh1 to enable mitotic exit (35, 37).

1.3.2 Cdk1 activators and inhibitors at cell cycle entry
In addition to cyclins, Cdk1 activators and inhibitors also control Cdk1 activity. Cell
cycle entry requires Cdk1 activating phosphorylation by Cak1 kinase (Cdk-activating kinase 1),
which phosphorylates Cdk1 at the T169 residue (38). Sic1 (subunit inhibitor of Cdk1) is a ClbCdk1 inhibitor during G1 phase (39). At the G1/S transition, Cln1/2-Cdk1 phosphorylates Sic1,
resulting in Sic1 recognition by SCFCdc4 (40, 41). Thus, Cln1/2-Cdk1 phosphorylation promotes
Sic1 degradation (40, 41). Cell cycle entry is similarly controlled in mammals by the Sic1
homologue p27 (42).
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1.4 S-Phase and DNA Replication
During S-phase, DNA is replicated to yield two identical sister chromatids. A complex
containing Cdk1 and an S-phase cyclin (S-Cdk1) has two distinct functions during S-phase. First,
S-Cdk1 triggers replication initiation, and secondly, it inhibits DNA re-replication after origin
firing. DNA replication is initiated by assembly of the Pre-Replicative Complex (Pre-RC) at
origins of replication (Figure 1.2). The Pre-RC is eventually turned into the Pre-Loading
Complex (Pre-LC) after S-Cdk1 phosphorylates Sld2 and Sld3 (Figure 1.2). Finally, DNA
polymerasee is loaded at the origin and replication is initiated to synthesize DNA. After origin
firing, S-Cdk1 phosphorylates Pre-RC components to disassemble the complex (43) (Figure 1.3).
Pre-RC disassembly ensures that DNA replication occurs only once per cell cycle.

1.4.1 DNA replication initiation
The Pre-RC is formed in early G1 phase when Cdk1 activity is low (Figure 1.2). Pre-RC
assembly begins when the six-subunit Origin Recognition Complex (ORC) binds to an origin of
replication (44, 45). The ORC recruits Cdc6, an essential AAA+ ATPase, which binds to the
origin in an ATP-dependent manner (46). The ORC-Cdc6 complex then recruits the replication
licensing factor Cdt1 to the origin (47). Cdt1 and Cdc6 recruit Mcm2-7 (Minichromosome
Maintenance Complex) to the origin (47, 48). Mcm2-7 is a six-subunit helicase that binds to the
Cdt1 C-terminus (49). The ORC-Cdc6 complex is necessary for efficient Mcm2-7 nuclear
localization (47, 50). After Mcm2-7 is loaded, Cdt1 is released from the origin (51, 52). The
ORC then directs a second Mcm2-7 hexamer to be loaded at the origin (53).
After assembly, the Pre-RC is activated by the Dbf4-Cdc7 complex, also known as DDK
(Dbf4-dependent protein kinase) (54). DDK phosphorylates Mcm2-7 to recruit Cdc45 and Sld3
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to the origin (54, 55). Cdc45 associates with Mcm2-7 in a manner that is dependent on S-Cdk1
and DDK activity (56). S-Cdk1 phosphorylates Sld2 and Sld3 (57). Sld2 phosphorylation and its
interaction with Dpb11 are key steps in converting the Pre-RC to the Pre-Loading Complex (PreLC) (58). The Sld2-Dpb11 complex recruits the GINS complex (Sld5, Psf1, Psf2, and Psf3) and
DNA Pole onto the origin (Figure 1.2) (58, 59). Cdc45, Mcm2-7, and the GINS complex
comprise the CMG helicase, which is required for fork progression. Mcm10 then associates with
the origin in a Cdk1-dependent manner, activates the CMG helicase complex, and unwinds DNA
(60, 61). After the DNA is unwound DNA pola is recruited and loaded onto chromatin (62, 63).
DNA pola primes the DNA for synthesis and then both DNA pold and DNA pole elongate the
newly synthesized DNA strands (64, 65).
Replication initiation is a conserved process. Cdc6 has homologs in S. pombe (Cdc18)
and humans (HsCdc6) that are also essential for DNA replication (66, 67). Cdt1 was originally
identified in S. pombe as a target of Cdc10, the fission yeast equivalent of Swi6 transcription
factor (68). Studies in S. pombe showed that Cdt1 interacts with the C-terminus of Cdc18 to
recruit Mcm2-7 to the origin (48). Dpb11 has an ortholog in humans (TopBP1) that similarly
loads DNA pole onto the origin (69).
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Figure 1.2. Pre-RC Assembly. The Pre-Replication Complex (Pre-RC) is assembled during G1. DDK,
Dbf4 and Cdc7, activates the Pre-RC complex, turning it into the Pre-Loading Complex (Pre-LC). SCDK phosphorylates Sld2 and Sld3 to promote Dpb11, DNA Polε and the GINS complex to associate
with origins. S-CDK also inhibits pre-RC assembly until the next cell cycle (Bell & Dutta, Annu. Rev.
Biochem. 2002)
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1.4.2 Mechanisms to prevent DNA re-replication
DNA replication occurs once and only once per cell cycle. Multiple rounds of DNA
replication during one cell cycle causes genome instability. After origin firing, Cdk1-dependent
mechanisms disassemble the Pre-RC to prevent DNA re-replication (Figure 1.3A). These
mechanisms include: Mcm2-7 nuclear export, ORC subunit phosphorylation, and Cdc6
degradation (70-73). Mcm2-4 and Mcm6 are phosphorylated by S-Cdk1, which results in nuclear
export (70). S-Cdk1 phosphorylates Orc2 and Orc6, causing steric hindrance to prevent Pre-RC
reassembly (71). Clb5 binds to Orc6 through a hydrophobic RXL patch and remains bound for
the remainder of S-phase (72). The Clb5-Orc6 interaction blocks Cdt1 and Mcm2-7 from binding
to the origin (Figure 1.3A and B) (72).
Mechanisms to prevent origin re-firing overlap and loss of multiple Pre-RC disassembly
mechanisms results in DNA re-replication. Mutations that lead to re-replication include: deleting
the Cdk1 motifs on Orc2 and Orc6 (ORC2-ps, ORC6-ps), mutating the Orc6 hydrophobic patch
(ORC6-rxl), adding a nuclear localization signal (NLS) on Mcm7 (MCM7-NLS), and/or deleting
the Cdc6 N-terminus (cdc6-DNT) (Figure 1.3C) (74, 75).
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Figure 1.3.Multple mechanisms prevent DNA re-replication (A) Clb5-CDK phosphorylates Orc2,
Orc6, Cdc6, and Mcm2-7 after origin firing. (B) Orc2 and Orc6 phosphorylation prevent origin
association. N-terminal and C-terminal Cdc6 phosphorylation by CDK promotes its degradation. Mcm27 phosphorylation results in nuclear export. (C) Pre-RC mutations synergistically cause re-replication.
Mutations in Orc2 and Orc6 phosphorylation sites, as well as deletion of the Orc6 RxL hydrophobic
patch prevents CDK phosphorylation. Deletion of Cdc6 N-terminal region results in its stabilization.
Adding a nuclear localization sequence (NLS) to the Mcm2-7 complex traps it in the nucleus.
(Archambault et al. Mol Cell Biol. 2005, Drury et al. EMBO J. 1997, Green et al. Mol Cell Biol. 2005)
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1.4.3 Regulation of Cdc6 protein level
Cdc6 protein levels fluctuate over the course of the cell cycle. Cdc6 is abundant during
G1 and then is rapidly degraded after DNA replication initiation (76). Cdc6 protein levels remain
low during S and G2 phases, and then accumulate in mitosis (76). Cdc6 stability is controlled by
three mechanisms: transcription, degradation, and localization. All three controls are affected by
Cdk1 activity.
CDC6 transcription takes place during late mitosis and G1 phases, when Cdk1 activity is
low. CDC6 transcription is controlled by the early cell cycle box (ECB) promoter element which
causes CDC6 mRNA accumulation at the M/G1 transition (77, 78).
There are three modes of Cdc6 protein degradation proposed by Diffley’s group (79).
Mode 1 refers to rapid Cdc6 degradation during G1, which does not require Cdk1
phosphorylation or ubiquitination by the SCFCdc4 (79). After origin firing, Cdc6 is degraded by
Mode 2 proteolysis, which is dependent on SCFCdc4 ubiquitination and a Cdc4 interaction domain
at the Cdc6 N-terminus (79). Mode 3 proteolysis occurs at the G2/M transition and is also
dependent on SCFCdc4, but requires a Cdc4 interaction domain at the Cdc6 C-terminus (79) Cdc6
has eight Cdk1 consensus sites (S/TP), seven of which are involved in protein stability (Figure
1.4) (73). Of these seven sites, four are at the N-terminus, three are at the C-terminus (Figure 1.4)
(61). CDK-dependent phosphorylation at the Cdc6 N-terminal phospho-degron, at T39 and S43,
leads to SCFCdc4 recognition (62). Cdc6 N-terminal deletion (amino acid 1-49) results in Cdc6
stabilization (63). Cdk1-dependent Cdc6 C-terminal phosphorylation at S372 primes and triggers
subsequent phosphorylation at T368 by Mck1, a homologue of GSK-3 kinase (80, 81). The Cterminal Cdc6 phospho-degron at T368 and S372 is recognized by SCFCdc4 for ubiquitination
(65). Mutation at T368 or S372 leads to Cdc6 stabilization (81).
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Cdc6 protein levels are also regulated by its localization. Cdc6 nuclear localization is
dependent on an N-terminal NLS (amino acid position 27-33) (82, 83). Cdc6 nuclear localization
promotes Cdc6 degradation and mutating the NLS results in Cdc6 stabilization (83).

*
T7 T23 T39 S43

*
S135

S354 T368 S372

Cdc6
29-32
NLS

ATPase Homology Domain
Figure 1.4. Schematic of Cdc6. CDK consensus motifs, ATPase Homology Domain and NLS are
shown. There 8 CDK consensus sites which include T7, &23, T39, S43, S135, S354, T368 and S372.
There are two phospho-degrons at T39-S43 and T368-S372 indicated by *. (Elsasser et al. Mol Cell
Biol. 1999, Luo et al. Biochem. Biophys. Res. Commun. 2003.)
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1.4.4 Replication-independent Cdc6 function
Evidence from several studies suggest that Cdc6 has an additional function during mitosis
that is distinct from DNA replication. In G2/M phases, Cdk1 activity prevents Cdc6 from
binding chromatin (84). During mitosis, Clb2 binds to the Cdc6 N-terminal region (71). Calzada
et al. showed that Cdc6 inhibits Cdk1 activity in a similar manner to Sic1 and Cdh1 (85). Sic1 is
a Clb-Cdk1 inhibitor, and Cdh1 is an APC binding partner that targets mitotic cyclins. A later
study showed that Cdc6 N-terminal deletion did not affect viability in sic1D and cdh1D deletion
cells (86). However, a recent study by Ord et al. showed that Cdc6 inhibits Clb2/Cdk1 activity in
vitro (87). These studies collectively demonstrate that Cdc6 also functions as a mitotic Cdk1
inhibitor. Cdc6, Sic1 and Cdh1 compensate each other for its function to inhibit Cdk1.
Boronat et al. observed that Cdc6 overexpression from the GAL promoter causes a
mitotic delay. They also observed that Cdc6 overexpression resulted in stabilization of proteins
that are normally ubiquitinated by APCCdc20. The mitotic delay phenotype was enhanced when a
CDC6-S372A phosphorylation mutant was overexpressed. Conversely, the mitotic arrest after
Cdc6 overexpression was rescued in cdc55D cells, which lack a regulatory subunit of Protein
Phosphatase 2A (PP2A). They further showed that Cdc55 and Cdc6 physically interact during
mitosis. These findings led Boronat et al. to propose a model where Cdc6 recruits PP2ACdc55 to
deactivate APCCdc20 (88, 89). This model is in contrast to the idea that stabilized Cdc6 prevents
APC activation by inhibiting Cdk1. Although Boronat’s model is consistent with studies that
showed that PP2ACdc55 dephosphorylates APC subunits, the precise mechanism of a Cdc55-Cdc6
interaction is not known (90, 91).
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1.5 Mitosis
DNA replication yields identical sister chromatids that are cohesed by a multiprotein
complex known as cohesin (92). During mitosis, sister chromatids are segregated into two
daughter cells. M-Cdk1, a protein complex consisting of Cdk1 and a mitotic cyclin (Clb1-4),
drives mitotic entry and progression. Mitotic entry is regulated by the inhibitory kinase Swe1 and
its counteracting phosphatase, Mih1, which both target M-Cdk1 (93). Mitosis consists of four
phases: prophase, metaphase, anaphase, and telophase (94). During prophase, chromatin is
condensed in preparation for segregation. In metaphase, the sister chromatid pairs are aligned at
the metaphase plate and the mitotic spindle attaches to the kinetochore protein complex at the
centromeric region of each chromatid (94, 95). At anaphase onset, cohesin is cleaved by separase
(Esp1) and tension from the mitotic spindle separates the chromatids towards opposing poles
(96). The anaphase inhibitor securin (Pds1), prevents the chromatid segregation by binding Esp1
in a Cdk1-dependent manner. APCCdc20 ubiquitinates Pds1 at anaphase onset, resulting in Esp1
release (97). In telophase, the mother and daughter cells undergo mitotic exit and prepare for
cytokinesis to yield two separate cell bodies.
In late mitosis, Cdk1-dependent phosphorylation is reversed by two serine-threonine
phosphatases: Protein Phosphatase 2A (PP2A) coupled to regulatory subunit Cdc55 (PP2ACdc55)
and Cdc14. PP2ACdc55 is an abundant protein that has multiple roles in cell cycle regulation, and
its activity is dependent on its localization (98). Cdc14 is sequestered to the nucleolus until its
release in anaphase when it facilitates mitotic exit (19). Mitotic exit requires M-Cdk1
downregulation, which is accomplished by mitotic cyclin degradation and the Cdk1 inhibitor
Sic1.
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1.5.1 Regulation of mitotic entry
Mitotic entry requires M-Cdk1 activity. Swe1 is a kinase that phosphorylates Cdk1 at the
tyrosine 19 residue (Y19), which inhibits Cdk1 activity and prevents mitotic entry (93). Swe1
accumulates during S-phase and is degraded at the G2/M transition (99, 100). The septin-binding
proteins Hsl1 and Hsl7 recruit Swe1 to the bud neck, where it is hyperphosphorylated by the
Cdc5 (101). The hyperphosphorylated Swe1 is ubiquitinated by SCFCdc4 and degraded (102).
When PP2ACdc55 is localized to cytoplasm, it also downregulates Swe1 (98, 103). Mitotic entry
is induced when Cdk1-Y19 phosphorylation is removed by the Mih1 (Mitotic Inducer Homolog)
phosphatase (104). Swe1 is also the central protein in the Morphogenesis checkpoint that
regulates the G2/M transition (105). The Morphogenesis checkpoint ensures that an appropriatesized bud is present before the cell enters mitosis (99). Thus, Swe1 prevents mitotic entry in
response to defects in morphology (106).
Cdk1 phosphoregulation at mitotic entry is conserved in higher eukaryotes. In humans,
the Swe1 homolog Wee1 phosphorylates Cdk1 at tyrosine 15 (Cdk1-Y15) to inhibit it (107). At
mitotic entry, Cdk1-Y15 phosphorylation is reversed by Cdc25, which is a homolog of Mih1
(104, 108).

1.5.2 Sister chromatid cohesion and segregation
Sister chromatid segregation is a critical step in cell division. Sister chromatids are
cohesed by a complex that consists of Scc1 (Sister chromatid cohesin), Smc1 (Stability of
minichromosomes) and Smc3 (109, 110). The cohesin subunits were first identified in a screen
that used a temperature sensitive cdc16-123 mutant and isolated mutants that were able to
segregate chromatids without APC function (109). The cohesin complex forms rings that are
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loaded along the length of the chromatid pairs (111). During metaphase, attachments are formed
between the mitotic spindle and the sister chromatids at the kinetochore. At the metaphase-toanaphase transition, Scc1 is cleaved by Esp1, and poleward tension from the mitotic spindles
segregate the chromatids (112).

1.5.3 Pds1-Esp1 interaction and the metaphase-to-anaphase transition
The metaphase-to-anaphase transition is triggered by separase, or Esp1 (Extra spindle
poles) (113). Esp1 is an essential protein that was initially discovered for its role in limiting
Spindle Pole Body (SPB) duplication (114). Later studies characterized Esp1 as a cysteine
protease that cleaves cohesin (115). Prior to anaphase, Esp1 is bound and inhibited by securin, or
Pds1 (Precocious dissociation of sisters) (116). Pds1 was first identified in two independent
screens: one screened for mutants that exhibited abnormal chromosome segregation, and the
other identified mutants that were inviable when treated with the microtubule-destabilizing agent
nocodazole (116, 117). The Pds1-Esp1 physical interaction requires Cdk1 phosphorylation at
three sites on the Pds1 C-terminus (S277, S292, T304) (Figure 1.5A) (118). The pds1-38 mutant
contains S/TàA mutations at the C-terminal Cdk1 sites and does not bind to Esp1 (119). The
Pds1 C-terminus also contains a Separase Interaction Site (residues 258 to 269) that is necessary
for Pds1-Esp1 binding (Figure 1.5A) (120). When Pds1 and Esp1 form a complex, Pds1 is
located in the Esp1 protease active site (120).
In addition to inhibiting Esp1 activity, Pds1-Esp1 interaction regulates Esp1 localization
(118, 121). Furthermore, Pds1 is necessary for Esp1 positioning at the mitotic spindle and the
SPBs (121). In pds1-38 cells, the concentration of Esp1 in the nucleus is reduced (118). Hornig
et al. proposed that the Pds1-Esp1 interaction is also a prerequisite for Esp1 activation (122). In
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their model, Pds1 binding induces a conformational change in Esp1 that brings the Esp1 N- and
C-termini into close proximity of each other to expose the Esp1 active site (122). The idea that
Pds1-Esp1 interaction is an Esp1-activating step is supported by in vitro evidence that the Esp1
N- and C-termini bind to each other, and Pds1 disrupts this interaction (122).
At anaphase onset, Pds1 is degraded through APCCdc20-dependent ubiquitination (35).
APCCdc20 recognizes a Destruction Box at the Pds1 N-terminus (Figure 1.5A) (123). The Pds1 Nterminus also contains two CDK consensus sites with unknown function (T27, S71), a predicted
NLS site (S71), and a KEN motif (residues 8-10) (Figure 1.5A) (124). After Pds1 is degraded,
active Esp1 is released, resulting in sister chromatid segregation (Figure 1.5B). Pds1 is stabilized
through several checkpoint mechanisms such as the SAC (Spindle Assembly Checkpoint), the
Intra-S checkpoint, and the DNA damage checkpoint, which leads to metaphase arrest (97, 125,
126).
The securin-separase interaction is conserved. The S. pombe Cut2 protein is a functional
homolog of budding yeast Pds1, and it binds and inhibits Cut1, a functional homolog of Esp1
(127). In humans, hSecurin/PTTG1 inhibits Separase/ESPL1 (128).
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Figure 1.5. Schematic of Pds1-Esp1 interaction. (A) Pds1 contains five Cdk1 consensus sites (T27,
S71, S277, S292, T304). The three C-terminal phosphorylation sites are adjacent to an Esp1 interaction
site (258-269) and are necessary for the Pds1-Esp1 physical interaction. The Pds1 N-terminus contains
a predicted nuclear localization sequence (NLS) (S71), a predicted KEN motif (8-10) and a confirmed
Cdc20
Destruction Box (84-93). The D-box is necessary for recognition by APC
. (Agarwal and Cohen-Fix.
Genes Dev. 2002, Hilioti et al. Curr Biol. 2001, Luo and Tong. Nature. 2017) (B) During metaphase,
Pds1 binds and inhibits Esp1. At the metaphase-to-anaphase transition, Pds1 is ubiquitinated by
Cdc20
APC
, resulting in Esp1 release. (Ciosk et al., Cell, 1998, Hornig et al, Curr Biol, 2002, Shirayama et
al., Nature, 1999)
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1.5.4 Esp1’s role in spindle elongation
Esp1 is activated by Cdk1-dependent phosphorylation and inhibited by PP2ACdc55
dephosphorylation (129). At anaphase onset, Esp1 cleaves Scc1 through its protease function and
promotes spindle elongation through an unknown mechanism (121). Cdc5 phosphorylates Scc1 at
residues adjacent to cleavage sites to promote Esp1 recognition (130). In addition to its primary
role as a protease, Esp1 promotes spindle elongation through a poorly understood mechanism.
Several pieces of evidence give insight into Esp1’s spindle function. First, Esp1 is localized to
spindles and SPBs in a Pds1-dependent manner (113). Second, the Esp1 catalytic domain is
necessary for spindle elongation (131). A temperature sensitive mutant, esp1-C113, contains a
mutation in the C-terminal domain and shows a defect in spindle elongation (131). Lastly, Esp1
has a second cleavage substrate, Slk19, which stabilizes the mitotic spindle in anaphase (112, 113,
132-134). Both ESP1 and SLK19 have genetic interactions with spindle-regulating genes,

supporting the premise that Esp1 promotes anaphase spindle elongation. Although Scc1 and
Slk19 are the only confirmed Esp1 cleavage targets, there are an additional thirty-five proteins
that contain the Esp1 core recognition motif of (D/E)XXR (135).

1.5.5 Other Esp1 functions in anaphase
Esp1 and its cleavage target Slk19 are both components of the FEAR (Cdc14 Early
Anaphase Release) pathway (134). The FEAR complex consists of Esp1, Slk19, and Cdc5,
which together mediate Cdc14 release (134, 136). Cdc14 is sequestered to the nucleolus by its
inhibitor, Net1, until early anaphase. At anaphase onset, the FEAR complex initiates Cdc14
release when Cdc5 phosphorylates Net1 (136). Continued Cdc14 release is dependent on
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activation of the MEN (Mitotic Exit Network). Cdc14 then reverses Cdk1-dependent
phosphorylation events, eventually resulting in mitotic exit.
PP2ACdc55 inhibits Cdc14 release by counteracting Cdc5-dependent Net1 phosphorylation
(137). During anaphase, active Esp1 downregulates Cdc55, thus allowing Cdc14 release and
promoting mitotic exit (138).

1.6 Cdk1-counteracting phosphatases in late mitosis
During late mitosis and mitotic exit, Cdk1 activity is inhibited and Cdk1-dependent
phosphorylation is reversed by the phosphatases PP2ACdc55 and Cdc14. PP2ACdc55
dephosphorylates Cdk1 substrates during late mitosis (20). Cdc14 is sequestered to the nucleolus
until anaphase, when it is released by the FEAR pathway (139). After release, Cdc14
dephosphorylates Cdk1 substrates to promote mitotic exit (140).

1.6.1 PP2ACdc55 overview
PP2A is a heterotrimeric serine/threonine phosphatase. PP2A consists of an A scaffolding
subunit (Tpd3), a B regulatory subunit (either Cdc55 or Rts1), and a C catalytic subunit (Pph21
and Pph22) (141, 142). Rts1 and Cdc55 direct PP2A to dephosphorylate different targets (143).
PP2ARts1 prevents chromosome missegregation during meiosis (143). PP2ACdc55 regulates
mitotic entry, progression, and exit (103, 144-146). Cdc55 function is dependent on its
localization, which is controlled by Zds1 and Zds2 (Figure 1.6) (90, 98, 147, 148). The Zds2 Cterminus physically interacts with Cdc55 to trap it in the cytoplasm (147). When PP2ACdc55 is in
the cytoplasm, it promotes mitotic entry by downregulating the M-Cdk1 inhibitor Swe1 (103).
Swe1 degradation derepresses M-Cdk1 and promotes mitotic entry (149). TheSwe1-Cdc55
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interaction also affects cell morphology as observed in cdc55

cells that have Swe1

accumulation, resulting in prolonged G2 phase and elongated buds (103). The morphological
defect in cdc55

cells is rescued by deleting SWE1 (103). PP2ACdc55-dependent mitotic entry is

also regulated by the Greatwall kinase (GWL) pathway (Figure 1.6) (150). A Greatwall-like
kinase Rim15 phosphorylates two endosulfines, Igo1 and Igo2, to activate them (151). Igo1 and
Igo2 bind to PP2ACdc55 to promote its nuclear export (Figure 1.6) (150). Zds1 and Zds2 are only
conserved in yeast, but inhibition of the human homologue of PP2ACdc55 (PP2A-B55) by the
GWL pathway is conserved (98, 150).
Cdc55 accumulates in the nucleus in zds1

zds2

cells (98). Nuclear PP2ACdc55 prevents

anaphase onset and mitotic exit (98). PP2ACdc55 inhibits anaphase onset by dephosphorylating
APC components Cdc16 and Cdc27 to deactivate the APC (Figure 1.6 (90). PP2ACdc55dependent APC inhibition promotes cell cycle arrest during spindle disruption as part of the
Spindle Assembly Checkpoint (SAC) (152). Nuclear PP2ACdc55 also inhibits mitotic exit by
preventing Cdc14 release (146). Cdc14 is sequestered in the nucleolus by its inhibitor Net1
(153). At anaphase onset, Cdc5 phosphorylates Net1, resulting in Cdc14 release (137, 153).
Nuclear PP2ACdc55 dephosphorylates Net1 to maintain Cdc14 sequestration and prevent mitotic
exit (Figure 1.6) (146). At anaphase onset, PP2ACdc55 is downregulated by Esp1 to allow Cdc14
release (137).
This project uses a cdc55-101 mutant that contains a point mutation at Gly43 to Asp,
resulting in Cdc55 nuclear exclusion (154). The cdc55-101 mutant was isolated from randomly
mutagenized cells in a screen for tom1

recessive-revertant suppressors. Tom1 is an E3

ubiquitin ligase that targets Cdc6 for degradation during G1 (155). Unlike cdc55 , cdc55-101
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cells show normal morphology, and therefore cell cycle progression can be monitored by the
budding index.
The mammalian homolog of PP2A has four variable regulatory subunits: B, B’, B’’, and
B’’’ (156). B55 is a homolog of Cdc55 and B’56 is a homolog of Rts1 (157). Human B55 has 4
isoforms: a, b, d and e (156). Human PP2A is a tumor suppressor and mutations in PP2A has
been found in solid tumors and lymphoma. PP2A inhibitors have also been shown to sensitize
cancer cells to treatment (158-160). PP2A-B55d dephosphorylates hSecurin, the human
homologue of Pds1, to stabilize it (161)
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inhibitions mitotic progression and exit by dephosphorylating the APC and preventing
Cdc14 release, respectively. (Juanes et al. PLoS Genetics, 2013, Rossio et al. JCB. 2011, Rossio et al.
JCS, 2013, Wang et al, MBC, 2006 ,Yang et al. MCB, 2000)
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1.7 Regulation of mitotic exit
Mitotic exit requires Cdk1 downregulation, which is facilitated by Cdc14 (19). Cdc14 is
released by the FEAR pathway at anaphase onset and Cdc14 activity is maintained by the MEN
(134, 162-164). In the FEAR pathway, Cdc5-dependent Net1 phosphorylation triggers Cdc14
release (137, 153). In the MEN pathway, Cdc5 deactivates the Bfa1/Bub2 complex (162).
Bfa1/Bub2 inhibits mitotic exit by downregulating GTPase Tem1 (165). Tem1 activates Cdc15
kinase, which in turn activates the Mob1/Dbf2 kinase complex (163-165). It has been proposed
that Mob1/Dbf2 complex creates a positive feedback loop that promotes Net1 phosphorylation
and maintains Cdc14 release (166).
Cdc14 downregulates Cdk1 activity through multiple mechanisms. Cdc14 activates Swi5,
a transcription factor necessary for the Cdk1-inhibitor Sic1 (19). Cdc14 also stabilizes Sic1
through dephosphorylation, thus preventing recognition by SCFCdc4 (19). Cdc14 promotes
mitotic cyclin degradation by dephosphorylating the APC binding partner Cdh1 (19). APCCdc20
ubiquitinates Clb2 to target it for partial degradation during anaphase and by APCCdh1 for full
degradation at mitotic exit (97, 167). M-Cdk1 downregulation by Clb2 degradation and by Sic1
are redundant mechanisms (37).

1.8 Spindle dynamics
The mitotic spindle attaches to sister chromatids at the kinetochore and separates them in
anaphase. Mitotic spindles consist of microtubule polymers that are nucleated at the spindle pole
bodies (SPBs), which are the equivalent of the mammalian microtubule organizing center
(MTOC) (168, 169). SPBs are duplicated during G1/S in a Cdk1-dependent manner (95). There
are two types of microtubules that extend from the SPBs: astral, which are located in the
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cytoplasm, and interpolar, which comprise the mitotic spindles (Summarized in Figure 1.7).
Microtubules are regulated by motor proteins, microtubule associated proteins (MAPs), and
tracking proteins.

1.8.1 Spindle pole body (SPB) duplication and spindle nucleation
Budding yeast undergo closed mitosis, where the nuclear envelope remains intact (169).
The mitotic spindle extends from the SPBs, which are embedded in the nuclear envelope (168,
169). SBPs are large protein complexes consisting of 18 subunits, 16 of which are essential (95).
Of the 18 core proteins, 11 of them have vertebrate orthologs that are present in the MTOC (95).
The SPB was initially identified by electron microscopy as a cylindrical structure that can access
both the nucleus and the cytoplasm from its position within the nuclear envelope (170). The SPB
components are categorized into three vertical layers, referred to as the outer, central, and inner
plaques (168). The inner component of the SPB is located in the nucleus and the outer portion is
in the cytoplasm (169).
SPB duplication begins in G1 and requires Cdc31, a calcium binding SPB subunit (95).
The new SPB is inserted into the nuclear envelope by the gamma-tubulin complex, which
consists of Tub4, Spc97, and Spc98 (171). Following SPB duplication, the two SPBs are tethered
by a bridge structure containing consisting of Sfi1 dimers (95). Completion of SPB duplication
has been observed in both G1 and S phases (95). After duplication, Sfi1 is phosphorylated by
Cdk1, resulting in separation of the two SPBs (Figure 1.7) (172). Esp1 limits SPB duplication to
once per cell cycle (114). In the esp1-1 temperature sensitive mutant, multiple SPB duplication
events occur resulting in extra spindle poles and a multipolar spindle (114).
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Microtubule nucleation occurs at the SPB and is carried out by the gamma-tubulin
complex (Tub4, Spc97, and Spc98) (173-175). The gamma-tubulin complex is assembled at the
cytoplasmic side of the SPB and transported into the nucleus by the NLS on Spc98 (174). S-Cdk1
phosphorylates Tub4 to initiate microtubule nucleation (95). Microtubules form as polar
molecules with plus and minus ends that consist of heterodimers of a-tubulin (either Tub1 or
Tub3) and b-tubulin (Tub2) (95). The minus end is located at the SPB and the plus end extends
away from the pole (95). Microtubules are present throughout the cell cycle as either cytoplasmic
astral microtubules or nuclear interpolar microtubules. Astral microtubules extend from the SPB
to the plasma membrane to form cortical attachments (95). These attachments provide force that
moves the nucleus towards the bud neck during mitosis (176). During metaphase, the mitotic
spindle exhibits dynamic instability, which is the result of microtubules alternating between
polymerization and depolymerization (177).
Dynamic instability occurs at both the plus and minus ends of the microtubule. The plus
ends of the microtubules are bound by the MAPs Bik1 and Bim1, which form a tetramer to
regulate spindle assembly (178). Bim1 promotes microtubule polymerization while Bik1 inhibits
polymerization (179, 180). Similarly, the MAP Stu2 contributes to spindle dynamicity by acting
as both a polymerase and destabilizer at the plus end (178). Cdk1 phosphorylates Stu2, causing it
to localize to the plus end and bind GTP-tubulin (181). Dynamic instability at the plus end
facilitates microtubule-kinetochore attachments and alignment of sister chromatids at the
metaphase plate.
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Figure 1.7. Spindle dynamics during cell cycle progression. During G1, astral microtubules (green)
are present at the Spindle Pole Body (SPB) (red) embedded in the nuclear envelope and position the
nucleus. In S-phase, the SPB is duplicated and microtubules are nucleated at the daughter SPB.
Interpolar microtubules extend from both SPBs. Astral microtubules attach to the cell cortex to position
the nucleus. In mitosis, the SPBs have interpolar microtubules which form microtubule-kinetochore
attachments. In anaphase, the Chromosome Passenger Complex (CPC) stabilizes the anaphase
midzone (Winey and Bloom. Genetics. 2012)
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1.8.2 Spindle activity during sister chromatid segregation
During metaphase, the microtubule plus end attaches to the kinetochore, a multi-protein
complex located on centromeric DNA (95). Early structural analysis showed that each
kinetochore is attached to a single microtubule (182). The outer kinetochore consists of three
protein complexes that form the KMN network (Knl1 complex, Mis12 complex, and Ndc80
complex) (95). Microtubule binding to the KMN network is mediated by the DASH Complex
(Dam1, Duo1, Ask1, Spc34, Spc19, and Hsk1) and inhibited by the CPC (Chromosome
Passenger Complex) which consists of Ipl1, Sli15, Bir1, and Nbl1 (183).
Microtubule-kinetochore attachments are made when the spindle interacts with the KMN
network (95). The CPC Aurora kinase Ipl1 phosphorylates Dam1 to prevent the DASH complex
from interacting with the KMN network (183, 184). Ipl1 also promotes kinetochore-microtubule
detachment through CPC activity (96). Ipl1 is localized at the kinetochore from G1 to metaphase
(96). In early mitosis, Sli15 is phosphorylated in an Ipl1-dependent manner, which prevents the
CPC from prematurely binding the mitotic spindle (185). Ipl1 phosphorylation events are
counteracted by Glc7 phosphatase (186). After anaphase onset, the CPC localizes to the
anaphase spindle midzone (95). The CPC components are conserved from yeast to humans. The
human homologs for Ipl1, Sli15, Bir1, and Nbl1 are Aurora B kinase, INCENP (inner
centromere protein), survivin, and borealin, respectively.
Microtubule force is generated by motor proteins. Interpolar microtubules are regulated
by the motor proteins Cin8, Kip1, and Kar3. Cin8 and Kip1 promote spindle elongation at the
plus ends and Kar3 promotes spindle disassembly at the minus ends (187-189). Therefore, Cin8
and Kip1 provide outward force, while Kar3 provides inward force (190). Kar3 has an additional
function in cross-linking antiparallel microtubules during anaphase to provide structural support
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(191). Kar3 localizes to the SPB, where it forms a complex with its binding partner, either Vik1
or Cik1. kar3 deletion causes short spindles due to a loss of cross-linking function (192). In
cytoplasmic microtubules, the opposing microtubule motor proteins Kip2 and Kip3 regulate
astral microtubule length and positioning (95).
MAPs that regulate mitotic spindle stability are Ase1, Stu1, and Stu2. Ase1 stabilizes
microtubules by bundling antiparallel microtubules at the spindle midzone (193). Stu1 and Stu2
destabilize microtubules. Stu2 promotes turnover at attached microtubule ends, resulting in
destabilization (194). Stu1 localizes to unattached kinetochores to prevent spindle stabilization,
which would result in premature chromatid separation (195).

1.8.3 Spindle dynamics during anaphase
During anaphase, the CPC relocates from the kinetochore to the anaphase spindle
midzone to stabilize the spindle (196). Cdc14 dephosphorylates Sli15, resulting in Sli15
relocation from the kinetochore to the midzone (197). The microtubule plus end tracking protein
Bim1 also facilitates Ipl1 movement to the spindle midzone (198). Premature Ipl1 relocation is
inhibited by Cdk1-dependent Ipl1 phosphorylation (198). At the spindle midzone, Ipl1 and Sli15
bind microtubules to stabilize them (197). Slk19, a kinetochore protein that is similarly relocated
to the spindle at anaphase, associates with the spindle in an Ipl1/Sli15-dependent manner to
further stabilize spindles (197). The microtubule bundling protein Ase1 binds and stabilizes
spindles independently of the Sli15-Ipl1 and Slk19 pathways (197). Ase1 forms dimers and
associates with the spindle through a microtubule binding domain, then crosslinks antiparallel
microtubules (199).
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Esp1 and Slk19 engage in genetic interactions with microtubule-associated proteins,
which may provide insight into how Esp1 promotes spindle elongation. SLK19 deletion is
synthetic lethal with deletion of minus-end motor protein KAR3 (132). Overexpression of KAR3
or CIK1 is lethal in the temperature sensitive esp1-1 mutant (200). Furthermore, Kip1, Cin8, and
Ase1 contain the Esp1 recognition motif and are candidate cleavage substrates (135).

1.9 Cell cycle checkpoints
Cell cycle checkpoints are control mechanisms that ensure the fidelity of cell division.
Accurate transmission of DNA is essential for genome stability. Correct passaging of genetic
information can be threatened both by exogenous factors such as UV or X-ray irradiation or
chemical mutagens and by endogenous factors such as DNA replication errors. DNA damage
activates cell cycle checkpoints such as the DNA damage response pathway, the Intra-S
checkpoint, and the SAC.
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Figure 1.8. Overview of the replication stress response and DNA damage response pathways.
The Intra-S checkpoint is activated by Mec1, which forms a complex with Ddc2. Mec1 then
Cdc20
phosphorylates and activates Rad53, which inhibits M-CDK and prevents APC
–dependent Pds1
ubiquitination. Red arrows represent pathways that are only active in DNA damage response. (Agarwal
et al., JBC, 2003,Palou et al. PLoS Genetics. 2015, Palou et al. Curr Gen. 2017, Sanchez et al., Science,
1999, Weinert et al. Science, 1994, )
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1.9.1 DNA damage checkpoint
DNA damage is a form of genotoxic stress that can be induced through multiple
techniques, including methyl methanesulfonate (MMS) treatment, CDC13 mutation, and DNA
re-replication. MMS is a DNA alkylating agent that causes double strand breaks (DSBs) (201).
Cdc13 is responsible for telomere maintenance (202). DNA re-replication also causes
chromosome breakage which triggers a DNA damage response (74).
DNA damage activates Mec1, an essential serine/threonine kinase (203). Mec1 initiates a
signaling cascade to arrest the cell cycle. Mec1 forms a complex with Ddc2 and localizes to sites
of DNA damage (Figure 1.8) (74, 204, 205). Mec1 phosphorylates and activates the adaptor
protein Rad9, which then stimulates Mec1 to phosphorylate the effector kinases Rad53 and Chk1
(206, 207). Rad53 has multiple downstream targets that eventually arrest the cell cycle (208).
Rad53 targets kinases Dun1 and Dbf4 and transcription factor Swi6 (209). Dun1 inhibits Cdc5 to
prevent Cdc14 release (162, 210, 211). Dun1 also phosphorylates DNA repair protein Rad55 and
ribonucleotide reductase inhibitor Sml1 (212, 213). Swi6 phosphorylation downregulates Cln1
and Cln2 transcription, and Dbf4 is inhibited from initiating late-origin replication forks (201,
214, 215). Rad53 also inhibits M-CDK and disrupts the interaction between Cdc20 and Pds1 to
stabilize the latter (Figures 1.8-1.9) (125, 216, 217). Chk1 phosphorylates Pds1 to prevent
APCCdc20-dependent ubiquitination (Figure 1.9) (126). Chk1 has nine consensus sites on Pds1
that are distinct from CDK consensus sites (208). Rad53 and Chk1 act in separate pathways to
stabilize Pds1: Rad53 prevents the Cdc20-Pds1 physical interaction while Chk1 prevents Pds1
ubiquitination (Figure 1.9) (125, 216).
DNA damage in re-replicating cells was confirmed by the presence of Ddc2 foci in rereplicating cells (74, 75). Ddc2 forms a protein complex with Mec1 at DNA damage sites. DNA
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re-replication also triggers Rad9 and Rad53 activation, which indicates that DNA re-replication
response is mediated by the Mec1 pathway (75).
Palou et al. showed that in addition to the Mec1 pathway, the SAC protein Mad2
maintains sister chromatid cohesion during MMS treatment (218). They also showed that Swe1
inhibits M-CDK in response to genotoxic stress and that it acts redundantly to Rad53 (Figure
1.8) (217). Other branches of the DNA damage checkpoint are the Rad17/Ddc1/Mec3 complex
and the MRX complex, which consists of Mre11, Rad50, and Xrs2. Rad17/Ddc1/Mec3 is the
equivalent of the human 9-1-1 complex and comprises a clamp structure that is loaded onto DNA
(219). The MRX complex has nuclease function and is involved in repairing double strand
breaks during meiosis (220). Rad52 also forms foci at sites of DSBs and stimulates repair (221,
222).

1.9.2 Replication Stress and Intra-S checkpoint
DNA replication stress is another form of genotoxic stress. DNA replication stress leads
to replication fork stalling, which in turn causes fork collapse. DNA replication stress can be
induced by hydroxyurea (HU) which depletes dNTP pools.
Multiple pathways contribute to cell cycle arrest during replication stress. The most wellstudied replication stress response pathway is the Intra-S checkpoint which is partially
overlapped with the DNA damage checkpoint response. The Intra-S checkpoint is a signaling
cascade activated by sensor kinase Mec1 (Figure 1.8) (223). Similar to the DNA damage
response, Mec1 binds to Ddc2 and the complex forms foci at sites of replication stress and DNA
damage (205). Mec1 phosphorylates Rad9 kinase, which recruits the effector kinase Rad53
(206). Mec1 phosphorylates Rad53 to activate it (208). The mediator kinase Mrc1 further
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promotes Rad53 recruitment and phosphorylation by Mec1 (224). Rad53 also inhibits M-Cdk1
activity and stabilizes Pds1 by disrupting the interaction between Pds1 and Cdc20 (216, 217).
Pds1 stabilization arrests the cell cycle at metaphase and prevents sister chromatid segregation
(113). Unlike double strand breaks, DNA replication stress does not induce Mec1 to activate
Chk1 (125).
In addition to the Intra-S checkpoint, Mad2 prevents sister chromatid segregation when
the Mec1-dependent pathway is disabled (Figure 1.8) (218). Mad2 is the central protein in the
SAC. The Cdk1 inhibitor Swe1 is also activated in response to genotoxic stress and inhibits MCdk1 in a pathway that is redundant to Rad53 (Figure 1.8) (217).
Rad53
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Cdc20

APC

Pds1

Rad9
Chk1

P
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Prevents
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Figure 1.9. Mec1 activates two effector kinases. Rad53 and Chk1 stabilize Pds1 by two distinct
mechanisms. Rad53 inhibits the interaction between Cdc20 and Pds1, while Chk1 phosphorylates Pds1
to prevent ubiquitination. Chk1 is only activated during DNA damage, while Rad53 is activated in
response to replication stress and DNA damage. (Agarwal et al., JBC, 2003, Sanchez et al., Science,
1999)
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1.9.3 Spindle Assembly Checkpoint (SAC)
The SAC is a signaling cascade that arrests the cell cycle in metaphase in response to
defects in microtubule-kinetochore attachments (36, 225-228). Loss of SAC function results in
chromosome missegregation and aneuploidy. SAC is activated by microtubule destabilizing
agents such as nocodazole and benomyl.
The SAC pathway consists of: Mad1-3, Bub1 and Bub3, and Mps1 (229-233). Mad1-3,
Bub1 and Bub3 were identified in genetic screen experiments using treatment with
benzimidazole (231, 233). Mps1 is a kinase that was initially identified for its function in SPB
duplication and was later characterized as a SAC component (229). Mps1 accumulates on
unattached kinetochores in early mitosis and is removed after microtubule attachments are made
(234). In fission yeast and other eukaryotes, Aurora B kinase promotes Mps1 localization to the
kinetochores (235). However in budding yeast, Ipl1 and Mps1 localize to the kinetochore
independently of each other (236).
SAC activation occurs via two separate pathways that are mediated by Sli15 and Mps1.
Cdk1 phosphorylates Sli15, which activates the SAC (237). In a separate pathway, Mps1 creates
a signaling cascade by phosphorylating Mad1 (229, 238-240). The signaling cascade is mediated
by Mad1, Bub1, and Bub3, which are localized at unattached kinetochores. Mad1 recruits Mad2
to the kinetochore, where they form a complex (241). Mad1/Mad2 association with the
kinetochore is dependent on Bub1 and Bub3 (242). At the kinetochore, Mad2 forms dimers in
both open and closed conformation, to create the MCC (Mitotic Checkpoint Complex) located
between the SAC proteins and Cdc20 (243). The MCC disrupts the APC D-box receptor and
prevents ubiquitin ligase activity (244, 245). A separate proposed SAC mechanism involves
Mad3 acting as a pseudosubstrate for APCCdc20 (96). In this mechanism, Mad3 is positioned so
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that its KEN box obscures the KEN box degron on Cdc20 (96). Therefore, Mad3 blocks
APCCdc20 access to Pds1 and Clb5 (96).
PP2ACdc55 inhibits APCCdc20 activity during spindle perturbation independently of the
SAC. PP2ACdc55 dephosphorylates the APC components Cdc16 and Cdc27(90). Cdc16 and
Cdc27 phosphorylation promotes Cdc20 association with the APC core proteins, and thus
PP2ACdc55 inhibits APCCdc20 activity (90).
When the correct kinetochore-microtubule attachments are made, the SAC proteins are
stripped from the kinetochore to deactivate the signaling cascade (96). The sister chromatids are
then segregated, leading to a loss of kinetochore tension. In order to prevent SAC re-activation
after chromosome segregation, Sli15 is dephosphorylated at Cdk1 consensus sites (246, 247).

1.10 Thesis Objective

The objective of this project is to characterize PP2ACdc55 function as a Cdk1counteracting phosphatase in how it regulates cell cycle progression and replication stress
response. The three aims of this thesis are to: 1. Examine how PP2ACdc55 regulates the
metaphase-to-anaphase transition through securin/Pds1; 2. Identify a role for PP2ACdc55 during
replication stress; 3. Elucidate the Cdc55-Cdc6 relationship and determine how this interaction
regulates S-phase entry and DNA replication control. In Chapter 2, my hypothesis was that
PP2ACdc55 inhibited untimely anaphase onset by targeting APC. In Chapter 3, I hypothesized that
PP2ACdc55 would also deactivate APC during the replication stress response, as this is how it
prevents sister chromatid segregation during spindle disruption. In Chapter 4, I hypothesized
that PP2ACdc55 is recruited by Cdc6 to promote cell cycle arrest during Cdc6 stabilization.
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Major findings from this study shows that PP2ACdc55 also directly targets Pds1 for
dephosphorylation. I also showed evidence for a novel role for PP2ACdc55 in dephosphorylating
Pds1 directly to regulate the Pds1-Esp1 interaction. Pds1 phosphorylation status regulates mitotic
spindle elongation rates and spindle morphology, and thus PP2ACdc55 activity inhibits premature
spindle elongation and poleward force. This function of PP2ACdc55 has implications in both
mitotic progression and replication stress response. Results from this study show a role for
nuclear PP2ACdc55 that is independent of known replication stress response pathways. Findings
from this study contradict previous results that showed a physical interaction between Cdc55 and
Cdc6 but confirm a genetic interaction. I further show evidence that the Cdc6-Cdc55 genetic
interaction has implications in the cell cycle response to DNA re-replication, as well as in Sphase entry.
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Chapter 2: PP2ACdc55 regulates Pds1 phosphorylation status in mitosis
2.1 Introduction
PP2ACdc55 is a Cdk1-counteracting phosphatase that can act in multiple pathways during
mitosis, and its function is dependent on its localization (98). Nuclear PP2ACdc55 inhibits mitotic
progression and exit by deactivating the Anaphase Promoting Complex (APC) and inhibiting
Cdc14 release, respectively (98). APC, when bound to activator Cdc20, triggers the metaphaseto-anaphase transition by ubiquitinating the anaphase-inhibitor Pds1, leading to its degradation
(97). Pds1 degradation results in the release of active Esp1 (113). In anaphase, Esp1 cleaves
cohesin and promotes spindle elongation, resulting in sister chromatid segregation (112).
In addition to inhibiting Esp1 activity, Pds1-Esp1 binding promotes Esp1 nuclear
localization (118). Pds1 is also necessary for Esp1 positioning specifically at the mitotic spindle
and SPBs (118, 121). The Pds1-Esp1 interaction is dependent on Cdk1 phosphorylation of Pds1
C-terminus at three sites (S277, S292, and T304) (118). When Pds1 and Esp1 are in a complex,
Pds1 is located in the Esp1 catalytic domain, as shown by crystal structure data (113, 120).
Esp1’s protease and spindle elongation functions both require the catalytic domain, although the
precise mechanism of how Esp1 promotes spindle elongation is not fully understood (120, 131).
Since Pds1 is a Cdk1 substrate, it is likely that PP2ACdc55 can regulate Pds1
phosphorylation status. Although previous work showed that PP2ACdc55 promotes Pds1
stabilization during spindle disruption by deactivating the APC (90, 91). It is unknown if
PP2ACdc55 regulates Pds1 stability during normal cell cycle conditions, or if PP2ACdc55 controls
Pds1 phosphorylation status.. Pds1 has five Cdk1 consensus sites that may be affected by
PP2ACdc55. In addition to the three C-terminal discussed above, Pds1 also has two N-terminal
Cdk1 consensus sites (T27, S71) with unknown function. The Pds1 N-terminus also contains a
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KEN motif and a Destruction Box that is necessary for Pds1 recognition by APCCdc20 (123). The
Pds1 S71 residue is also part of a predicted NLS motif (124). Thus, Pds1 N-terminal
phosphorylation may affect Pds1 stability or localization.
The following chapter examines how PP2ACdc55 regulates Pds1 phosphorylation status
during mitosis, as well as downstream effects of Pds1 hyper- and hypo- phosphorylation.
Findings presented in this chapter show that PP2ACdc55 directly dephosphorylates Pds1, and that
Pds1 phosphorylation status is associated with mitotic spindle integrity and elongation rate. This
chapter contains data from a collaboration with Devon Chandler-Brown from the Skotheim Lab
at Stanford University and Sam Kajjo from the Rudner Lab at University of Ottawa.
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2.2 Results
2.2.1 Pds1 is hyperphosphorylated in cdc55-101 cells
Since PP2ACdc55 inhibits APC activity, and APCCdc20 promotes Pds1 degradation, I
expected that Cdc55 nuclear exclusion would destabilize Pds1 (97). To examine how nuclear
PP2ACdc55 regulates Pds1, cdc55-101 and wild-type (WT) cells were used. The cdc55-101 strain
is a localization mutant that only has Cdc55 in the cytoplasm, while WT cells have normal
Cdc55 distribution in the nucleus and cytoplasm (90). WT and cdc55-101 cells were
synchronized in G1 phase and released for one cell cycle. Pds1 protein was monitored in 15minute intervals. Pds1 migrated as two distinct bands, consistent with prior reports that showed
that the upper band represented phosphorylated Pds1 (118). There was no obvious difference in
Pds1 degradation, as Pds1 was degraded by t=90 minutes in both WT and cdc55-101 cells
(Figure 2.1A). Pds1 was hyperphosphorylated at t=45 minutes and t=60 minutes in cdc55-101
compared to WT (Figure 2.1A). This result suggests that nuclear PP2ACdc55 does not regulate
Pds1 stability but instead may regulate Pds1 phosphorylation status during normal cell cycle
conditions.
To confirm that the Pds1 upper band represented the hyperphosphorylated form of the
protein, Pds1 protein was purified and treated with calf intestinal phosphatase (CIP) with or
without a phosphatase inhibitor (Figure 2.1B). If the upper band represents Pds1 phosphoprotein,
CIP treatment should remove the upper band, while CIP treatment with a phosphatase inhibitor
should preserve the two-band migration pattern. The Pds1 upper band (**) was abolished the
CIP-treated sample and present in the CIP+Inhibitor sample, confirming that the upper band is
hyperphosphorylated Pds1 (Figure 2.1B).
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Figure 2.1. Pds1 is transiently hyperphosphorylated in cdc55-101. (A) PDS1-HA CDC55 (WT) and
PDS1-HA cdc55-101 (cdc55-101) cells were arrested in G1 by alpha factor and released into YPD.
Samples were taken at the indicated times for western blot analysis. Pds1-HA was detected using antiHA. Pgk1 is shown as a loading control. (B) Pds1-HA was immunoprecipitated using anti-HA beads.
The purified proteins were subjected to 37ºC in the presence of CIP or CIP with a phosphatase inhibitor.
An untreated sample is shown as a control. (** represents upper Pds1 band, * represent lower Pds1
band)
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2.2.2 PP2ACdc55 directly dephosphorylates Pds1
Although Pds1 hyperphosphorylation in cdc55-101 indicates that PP2ACdc55 regulates
Pds1 phosphorylation status, it was still unknown if PP2ACdc55 dephosphorylates Pds1 directly or
if there are additional factors involved. To test if PP2ACdc55 directly dephosphorylates Pds1, an in
vitro phosphatase assay was performed (Figure 2.2). This experiment was carried out by Sam
Kajjo in Adam Rudner’s Lab at University of Ottawa. In this assay, HA-tagged Pds1 was
immunoprecipitated from yeast cells and then phosphorylated in vitro by purified Cdk1-Clb2. As
a control, a tagged Pds1-5A variant, was also purified from yeast and treated with Cdk1-Clb2.
Pds1-5A contains mutations that abolish all five Cdk1 consensus sites (T27A, S71A, S277A,
S292A, T304A) (248). Wild type Pds1 showed more phosphorylation than Pds1-5A, supporting
the premise that Cdk1 phosphorylates Pds1 at the five consensus sites (Figure 2.2A). Pds1-5A
showed mild phosphorylation, possibly as a result of an excess of g-32P
Phosphorylated Pds1 was then treated with purified PP2ACdc55. Pds1 w5as partially
dephosphorylated after 10 minutes of treatment with PP2ACdc55 and fully dephosphorylated by
30 minutes (Figure 2.2B). As a control, they also performed the experiment without PP2ACdc55
for 60 minutes and showed that there was no significant loss of phosphorylated Pds1 during
incubation (Figure 2.2B). This control experiment confirms that the loss of the Pds1
phosphoprotein band in PP2ACdc55-treated samples is specifically due to PP2ACdc55 activity,
rather than degradation. From these findings, I concluded that PP2ACdc55 directly
dephosphorylates Pds1 and reverses Cdk1-dependent phosphorylation at the five known
consensus sites.
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Figure 2.2. PP2A
dephosphorylates Pds1. An in vitro phosphatase assay was carried out by Sam
Cdc28
Kajjo in the laboratory of Dr. Adam Rudner (A) Purified Pds1-3HA protein was incubated with Clb2
complex and g-32. Pds1-5A-3HA contains mutations at CDK consensus sites. Non-tagged strain (Pds1)
was used as a negative control. Samples were subjected to SDS-PAGE to detect g -32P. (B) TAPCdc55
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collected 10, 30 or 60 minutes after incubation at room temperature and subjected to SDS-PAGE to
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detect g -32P. The phosphorylated Pds1-3HA was incubated without PP2A
and was incubated for
60min as a control.
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2.2.3 Deleting CDC55 strengthens the Pds1-Esp1 physical interaction
Both in vivo and in vitro results showed that PP2ACdc55 dephosphorylates Pds1. I next
focused on downstream effects of Pds1 dephosphorylation. Pds1 C-terminal phosphorylation is
known to facilitate the Pds1-Esp1 physical interaction (118). Therefore, I hypothesized that
PP2ACdc55 activity would prevent Pds1-Esp1 binding due to Pds1 dephosphorylation. To test if
PP2ACdc55 affects Pds1-Esp1 binding efficiency, I performed a co-immunoprecipitation assay
using WT and cdc55D cells that had Esp1-MYC and Pds1-HA. Pds1 that was coimmunoprecipitated with Esp1 showed a mobility shift compared to Pds1 protein in Input,
consistent with the idea that only phosphorylated Pds1 binds to Esp1 (Figure 2.3A)(118). The
ratio of Pds1 to Esp1 protein level was quantified, and this value was used to represent binding
efficiency. Pds1-Esp1 binding was enhanced in cdc55D compared to WT (Figure 2.3B). This
finding supports a scenario where PP2ACdc55 dephosphorylates Pds1 to prevent Pds1-Esp1
binding.
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Figure 2.3. Pds1-Esp1 binding is enhanced in the absence of Cdc55. (A) PDS1-6HA ESP1-9MYC
(WT) and PDS1-6HA ESP1-9MYC cdc55𝛥 (cdc55𝛥) cells were grown asynchronously.
Immunoprecipitation was performed with anti-MYC agarose beads. Esp1-MYC and Pds1-HA levels
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represents average of three independent experiments. Error bars represent SEM. *p<.05 (Student’s t
test)
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2.2.4 cdc55-101 cells undergo accelerated spindle elongation
The Pds1-Esp1 physical interaction is necessary for efficient Esp1 nuclear localization,
making it likely that Pds1 phosphorylation status affects Esp1’s ability to access its anaphase
targets (e.g. the cohesin subunit Scc1) (118, 121). In anaphase, Esp1 cleaves cohesin through its
protease function and promotes spindle elongation by an unknown mechanism (112, 121). Since
phosphorylated Pds1 binds to Esp1 and blocks its protease active site, it is unlikely that cohesin
cleavage would be altered in cdc55-101 (118, 120). This is also supported by findings presented
in Chapter 3 which show that Pds1 hyperphosphorylation does not affect cohesin cleavage
during a decelerated cell cycle. I therefore focused on spindle elongation in cdc55-101, since it is
the other main Esp1 function.
TUB1-GFP cells, which have fluorescently tagged microtubule subunits, were used to
visualize mitotic spindles. WT and cdc55-101 cells with TUB1-GFP were synchronized in G1
and spindles and were examined by fluorescence microscopy for one cell cycle. At t=60 minutes,
there were fewer cdc55-101 cells with short spindles compared to WT (36.3% in cdc55-101
compared to 61% in WT) (Figure 2.4, Left t=60). At the same time point, cdc55-101 cells had
more long spindles compared to WT (31.0% in cdc55-101 compared to 13.3% in WT) (Figure
2.4, Right t=60). Therefore, the short spindles were formed at the same time in WT and cdc55101 cells, but the cdc55-101 cells started exhibiting long spindles prematurely. These results
suggest that cdc55-101 cells undergo rapid spindle elongation after initial short spindle
formation. The time points where the most striking difference in long spindle abundance
corresponded with the time point where Pds1 was hyperphosphorylated in cdc55-101 (Figure
2.1A, t=60 and Figure 2.4, t=60). Taken together, these findings indicate a correlation between
Pds1 hyperphosphorylation and spindle elongation.
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Figure 2.4. cdc55-101 cells exhibit premature spindle elongation. (A) TUB1-GFP CDC55 (WT)
and TUB1-GFP cdc55-101 (cdc55-101) cells were grown in low fluorescence media, arrested in G1 by
alpha factor, and released. Samples were taken at the indicated time points for imaging by
fluorescence microscopy. Tub1-GFP was visualized using the FITC filter. Graphs show the average of
three independent experiments. Error bars represent SEM. Blue=WT; Orange=cdc55-101. (B)
Representative images from t=60 min are shown. *p-value<0.05 (Student’s t-test)
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2.2.5 Pds1 C-terminal phosphorylation is linked to spindle elongation and structure
My findings showed a correlation between Pds1 phosphorylation status and spindle
elongation. I hypothesized that the accelerated spindle elongation in cdc55-101 cells was a result
of altered Pds1-Esp1 binding. Pds1-Esp1 binding is facilitated by Cdk1-dependent
phosphorylation at three Pds1 C-terminal phosphorylation sites (S277, S292, T304) (118). Prior
evidence from Reed’s lab showed that Esp1 is necessary for anaphase spindle elongation and that
Pds1 is necessary for Esp1 positioning at the SPBs and mitotic spindle (121). A scenario where
Pds1 phosphorylation promotes Esp1 localization to the spindle would be consistent with Jensen
et al.’s findings.(121) To test if Pds1’s association with Esp1 affects spindle elongation, I used
the pds1-38 mutant (118). The pds1-38 mutant contains S/TàA mutations at the three Cdk1
consensus sites (S277, S292, T304), and therefore does not bind Esp1 (118). I hypothesized that
spindle elongation would be suppressed in pds1-38 as a result of inefficient Esp1 nuclear
localization. This would confirm that Esp1’s spindle elongation function is dependent on Pds1
phosphorylation status.
Pds1 phosphorylation status was monitored over one cell cycle in WT and pds1-38 cells
in a time course. pds1-38 cells only showed a hypophosphorylated Pds1 band through the entire
cell cycle, suggesting that Pds1 is only phosphorylated at the C-terminus during normal cell
cycle conditions (Figure 2.5). Spindle elongation was also examined over the course of one cell
cycle in WT and pds1-38 cells. Both WT and pds1-38 cells showed a decrease in short spindles
between t=45 minutes and t=60 minutes (41.6% to 15.3% in WT and 23.6% to 9.6% in pds1-38)
(Figure 2.6A). Between t=60 and t=75 minutes, WT cells showed an increase in long spindles,
while pds1-38 cells showed a decrease in long spindles at these time points (20.3% to 26.6% in
WT compared to 27.6% to 13.3% in pds1-38) (Figure 2.6A). Thus, in WT cells, a decrease in
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short spindle abundance was coupled with an increase in long spindles. In contrast, pds1-38 cells
showed a decrease in both short and long spindles over time, suggesting that short spindles were
formed but did not stably elongate. Spindles in pds1-38 cells also showed abnormal morphology.
Long spindles in pds1-38 were more likely to be asymmetrical or to break unevenly than
compared to WT spindles (Figure 2.6B). Abnormal spindle morphology in pds1-38 cells may
indicate that these spindles are structurally defective, resulting in their inability to elongate.
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Figure 2.5. Pds1 remains unphosphorylated throughout cell cycle in pds1-38 cells. PDS1-HA
(WT) and pds1-38 (pds1-38) cells were arrested in G1 by alpha factor and released into YPD. Samples
were taken at the indicated times for western blot analysis. Pds1-HA was detected using anti-HA. Pgk1
is shown as a loading control.
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Figure 2.6. pds1-38 cells show altered spindle dynamics compared to WT. (A) TUB1-GFP (WT)
or TUB1-GFP pds1-38 (pds1-38) cells were subjected to a time course as described in Figure 2.4.
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2.2.6 Altered spindle dynamics are not due to cell cycle status or chromatid
segregation in either pds1-38 or cdc55-101 cells
Flow cytometry and sister chromatid segregation data was performed using WT, cdc55101, and pds1-38 cells during one synchronized cell cycle. At t=45 and t=60 minutes after G1
release, all strains were in G2/M phase, indicating that altered spindle elongation timing was not
due to cells being in difference cell cycle stages (Figure 2.7A).
In order to determine if altered spindle elongation corresponded with altered chromatids
segregation patterns, propidium-iodide stained cells were examined by fluorescence microscopy
to determine chromatid segregation status. Unexpectedly, cdc55-101 cells showed delayed sister
chromatid segregation. At t=60 minutes, 30% of WT cells had segregated sister chromatids,
compared to 2% of cdc55-101 cells. At t=75 minutes, 44% of cdc55-101 cells had segregated
sister chromatids, compared to 58% of WT cells. Therefore, cdc55-101 cells showed a delay in
sister chromatid segregation timing, which was the reverse of the trend observed in spindle
elongation (Figure 2.7B compared to Figure 2.4). These findings show that spindle elongation
and sister chromatid segregation are not temporally correlated in cdc55-101 cells, and further
suggest that these two processes are regulated independently of each other.
Propidium iodide-stained pds1-38 cells were similarly examined to determine if spindle
accumulation corresponded with sister chromatid segregation. At t=60 minutes, 2% of pds1-38
cells had fully segregated sister chromatids compared to 30% of WT cells. At t=75 minutes,
pds1-38 and WT cells both showed 58% of cells with fully segregated chromatids. These
findings indicate that the decrease in short spindles in pds1-38 cells at t=60 minutes was not
temporally correlated with sister chromatid segregation.
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Figure 2.7. Altered spindle elongation in cdc55-101 and pds1-38 cells is not due to changes in
cell cycle stage or sister chromatid segregation. (A) WT, cdc55-101, and pds1-38 cells were
subjected to a time course as described in Figure 2.4. Samples were taken at the indicated time points
and stained with propidium iodide. Cell cycle profile was determined by flow cytometry. (B) Samples
from (A) were examined by fluorescence microscopy. Cells were categorized by budding and sister
chromatid segregation status. Blue= Unbudded or G1; Orange= Small-budded or S/G2 phase; Gray=
Large-budded or Mitosis with unsegregated sister chromatids; Yellow= Large-budded or Mitosis with
segregated sister chromatids
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2.2.7 Accelerated spindle elongation in cdc55-101 cells and altered spindle structure in
pds1-38 cells is recapitulated by live cell imaging
In order to observe spindle elongation in growing cells, time-lapse microscopy was
performed by Devon Chandler-Brown in Dr. Jan Skotheim’s lab at Stanford University. The time
point where a Tub1-GFP first appears is designated as time 0 min (Figure 2.8, yellow arrows).
The time lapse then follows the cell as the Tub1-GFP dot elongates to short spindles and
eventually to long spindle. In WT cells, symmetric long spindles are formed within 30 min
(Figure 2.8A). Consistent with my time-course data in Figure 2.6, the time-lapse images also
showed abnormal spindle morphology in pds1-38 cells (Figure 2.8B, blue arrow). 41% of pds138 cells also formed short spindles that shuttled between the mother and daughter cell bodies,
compared to 23% WT cells that exhibited this movement (Figure 2.8B, red arrows). This
shuttling movement raises the possibility that pds1-38 cells have a defect at the SPBs that affects
spindle anchoring.
Taken together, these findings suggest that Pds1 C-terminal phosphorylation promotes
spindle integrity as well as elongation rate. Pds1 phosphorylation status had a more prominent
effect on long spindles than on short spindles, suggesting that short spindle formation is
regulated separately from elongating spindles. Asymmetrical spindles in pds1-38 cells may
indicate uneven tension at the SPBs where the spindles are anchored. The idea that spindle
anchoring at the SPB is defective in pds1-38 cells is further supported by the short spindle
shuttling seen by time-lapse microscopy. Since Pds1 is necessary for Esp1 localization at the
SPBs, a potential explanation is that Esp1 presence at the SPB is necessary for correct spindle
tension (131).
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Figure 2.8. pds1-38 cells show short spindle shuttling between mother and daughter cell bodies.
TUB1-GFP (WT) or pds1-38 TUB1-GFP (pds1-38) were observed by time-lapse fluorescence
microscopy. Cell images were taken every three minutes. 0 min image represents the point where a
Tub1-GFP signal was first detected. Yellow arrow shows highlighted spindle. Fully elongated spindles
are labeled as “Long Spindle”. Red arrows show shuttling movement. Blue arrow shows abnormal
spindle morphology. This experiment was performed by Devon Chandler-Brown in the laboratory of Dr.
Jan Skotheim.
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To determine which stage of spindle elongation is accelerated in the cdc55-101 cells, the
time points were identified where short spindles and long spindles initially appeared for each
individual cell in the time lapse imaging movies. Short spindle formation was defined as the time
point where the Tub1-GFP structure initially showed greater length than width, and long spindle
formation was defined as the time point where the spindle first exceeded 2µM in length. WT and
cdc55-101 cells took an average of 39.17±0.98 and 40.44±1.25 minutes, respectively, between
bud emergence and short spindle formation (Figure 2.9A). Therefore, short spindles were formed
at approximately the same time in WT and cdc55-101 cells. In contrast, the time needed to
elongate a short spindle to >2µM was reduced in cdc55-101 cells compared to WT. Timespan
between short spindle and long spindle formation was 38.13±1.51 minutes for WT cells and
34.32±2.3 minutes for cdc55-101 cells (Figure 2.9B). Spindle elongation events were also
determined for each individual pds1-38 cell. pds1-38 cells took an average of 42.3±1.85 minutes
spanning from bud emergence to short spindle formation, and 40.0±2.3 minutes spanning from
short spindle to long spindle formation. This result indicates that the time needed for pds1-38
cells to create short spindles and to elongate short spindles to long spindles were both
comparable to WT cells. Cells that underwent prolonged short spindle shuttling and did not
complete anaphase were not included in the time span counts.
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Figure 2.9 Duration of spindle elongation is reduced in cdc55-101 cells. Time-lapse microscopy
was performed on TUB1-GFP (WT), cdc55-101 TUB11-GFP (cdc55-101), and pds1-38 TUB1-GFP
(pds1-38) cells. Images were taken every 3 minutes. The time spanning between bud emergence and
formation of a short spindle (left) and the time spanning between short spindle formation and long
spindle formation (right) were determined for each individual cell. Images were obtained by Devon
Chandler-Brown in the laboratory of Dr. Jan Skotheim.

57

2.2.6 Pds1 is downstream of PP2ACdc55 in the spindle elongation pathway
Next, I tested if accelerated spindle elongation seen in cdc55-101 cells was specifically
due to Pds1 C-terminal hyperphosphorylation. Although the in vitro phosphatase assay
confirmed that PP2ACdc55 dephosphorylates Pds1 at the Cdk1 consensus sites, it is not conclusive
if Pds1 phosphorylation by Cdk1 regulates spindle elongation. Therefore, to confirm that
PP2ACdc55 is upstream of Pds1 dephosphorylation in the spindle elongation pathway, I used
cdc55-101 pds1-38 to test for an epistatic relationship. Pds1 phosphorylation status was tracked
over the course of one cell cycle in pds1-38 and pds1-38 cdc55-101 cells. Neither pds1-38 nor
pds1-38 cdc55-101 cells showed a Pds1 phosphoprotein band, which implies that PP2ACdc55 only
targets the Pds1 C-terminus in normal cell cycle conditions (Figure 2.10). Pds1 protein levels
were also transiently elevated in pds1-38 cdc55-101 compared to pds1-38 at t=60 minutes
(Figure 2.10, t=60). Since Pds1 was unphosphorylated in both pds1-38 nor pds1-38 cdc55-101
cells, Pds1 protein levels are most likely regulated independently of phosphorylation. If
PP2ACdc55 dephosphorylates Pds1 to inhibit spindle elongation, pds1-38 and pds1-38 cdc55-101
cells should show identical spindle elongation patterns. To confirm that Pds1 is downstream of
PP2ACdc55 in the spindle elongation pathway, spindle elongation rate was monitored in pds1-38
and pds1-38 cdc55-101 cells over one cell cycle. The pds1-38 and cdc55-101 pds1-38 cells
showed the same trends in both short spindle and long spindle abundance (Figure 2.11A).
Similarly, both pds1-38 and pds1-38 cdc55-101 cells showed abnormal spindle morphology
(Figure 2.11B). Taken together, these findings confirm that Pds1 is downstream of PP2ACdc55 in
the spindle elongation pathway.
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Figure 2.10. Cdc55 nuclear exclusion does not affect Pds1 phosphorylation status in pds1-38
cells. Pds1-3HA levels and phosphorylation status in pds1-38-3HA and cdc55-101 pds1-38-3HA cells
were examined by western blot analysis during a time course as described in Figure 2.1
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Figure 2.11. Cdc55 nuclear exclusion does not affect spindle elongation timing in pds1-38 cells.
(A) pds1-38 TUB1-GFP (pds1-38) and cdc55-101 pds1-38 TUB1-GFP (cdc55-101 pds1-38) cells were
subjected to a time course as described in Figure 2.4. Images were taken at the indicated time points.
The number of cells exhibiting short spindles (Left) and long spindles (Middle) were counted. Graphs
represent the average of 3 independent experiments. Error bars represent SEM. Orange= pds1-38;
Green = pds1-38 cdc55-101. (B) Representative images from t=75 are shown (Right)
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2.2.7 Pds1 phospho-regulation affects its localization
Although there is evidence that Esp1 nuclear localization requires Pds1 C-terminal
phosphorylation, it is unknown how Pds1 localization is regulated (118). If spindle elongation is
dependent on Esp1 nuclear localization, it is likely also dependent on Pds1 localization. A
possible mechanism for regulating Pds1 localization is through a predicted NLS motif at S71
(124). The Pds1 S71 residue is also one of the five Cdk1 phosphorylation sites that is
dephosphorylated by PP2ACdc55.
To test if PP2ACdc55 regulates Pds1 localization, Pds1-GFP was visualized in WT and
cdc55-101 cells in a time course. At t=45 minutes, 62.3% of cdc55-101 cells showed Pds1
nuclear localization, compared to 31.3% of WT cells (Figure 2.12). This result suggests that
either nuclear PP2ACdc55 inhibits Pds1 nuclear localization, or that cytoplasmic PP2ACdc55
promotes Pds1 nuclear localization. Time course data using pds1-38 cdc55-101 cells suggested
that nuclear PP2ACdc55 only dephosphorylates the Pds1 C-terminus in normal cell cycle
conditions (Figure 2.12). However, it is still possible that Pds1 N-terminal phosphorylation too
transient to observe in 15-minute intervals.
To confirm that Pds1 hyperphosphorylation has a positive correlation with nuclear
localization, I monitored pds1-38-GFP localization over one cell cycle. pds1-38-GFP cells
showed a similar localization pattern as WT at t=45 minutes. However, at t=60 minutes, 21.6%
of pds1-38 cells showed Pds1 nuclear localization, compared to 41.6% of WT cells (Figure
2.13). From this result, it can be concluded that Pds1 localization is influenced by C-terminal
phosphorylation, and that Pds1 phosphorylation may be necessary for sustained nuclear
localization.
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Figure 2.12. Pds1 prematurely localizes to the nucleus in cdc55-101 cells. (A) PDS1-GFP (WT)
and PDS1-GFP cdc55-101 (cdc55-101) cells were subjected to a time course as described in Figure
2.4. Images were taken at the indicated time points. Chart shows average of three independent
experiments. Error bars represent SEM. Blue=WT, Red=cdc55-101. (B) Representative images from
t=45 are shown. *p-value<0.05 (Student’s t-test)

62

A

% of cells with nuclear Pds1-GFP
100

WT
pds1-38

% cells

80
60

*

40
20
0
0

15

30

45

60

75

90

Time (min)

B

DIC

Pds1-GFP

Overlay

WT

pds1-38

Figure 2.13. pds1-38-GFP does not remain in the nucleus during mitosis. (A) PDS1-GFP (WT)
and pds1-38-GFP (pds1-38) cells were subjected to a time course as described in Figure 2.4. Images
were taken at the indicated time points. Chart shows average of three independent experiments. Error
bars represent SEM. Blue=WT, Red=cdc55-101. (B) Representative images from t=60 are shown. *pvalue<0.05 (Student’s t test)
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2.2.8 Additional genetic interactions exist between Pds1 and Cdc55
In order to confirm that there is an epistatic relationship between Pds1 and Cdc55, I
attempted to construct a pds1D cdc55-101 strain. The pds1D cdc55-101 double mutants were
inviable (Figure 2.14). This finding was consistent with an earlier study showing that pds1D
cdc55D double mutants were inviable, and further suggests that synthetic lethality is specifically
due to the loss of nuclear PP2ACdc55 (152). Synthetic lethality between pds1D and cdc55-101
indicates that there are additional genetic interactions between Pds1 and Cdc55. A possible
explanation for pds1D cdc55-101 being inviable is that PP2ACdc55 inactivates Esp1, as a recent
study has shown (129). Another possible explanation is that in pds1D cdc55-101 cells, Esp1 is
present in the nuclear at low concentrations but cleaves cohesin and elongates spindles in an
unregulated manner, leading to severe genomic instability.
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Figure 2.14. cdc55-101 pds1𝛥 double mutants are inviable. CDC55-MYC::KanMX/CDC55-wt PDS1wt/pds1D::TRP (top) and cdc55-101-MYC::KanMX/CDC55-wt PDS1-wt/pds1D::TRP (bottom) diploid
strains were sporulated, and tetrads were dissected on YEPD plates, incubated for 3 days at room
temperature. Genotypes were determined by replica-plating. Inviable spores were genotyped by
assuming 2:2 segregation. The presence of cdc55-101 (m; left symbol) or CDC55-wt (+; left symbol)
and the presence of the pds1D allele (m; right symbol) or PDS1-wt (+; right symbol) in each colony is
indicated.
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2.3 Discussion
2.3.1 Pds1 regulation by PP2ACdc55
Findings presented in this study show that nuclear PP2ACdc55 dephosphorylates Pds1
directly and specifically targets Cdk1 consensus sites. Since Pds1 is degraded in late mitosis,
which is when PP2ACdc55-dependent dephosphorylation controls cell cycle progression, the
possibility of Pds1 dephosphorylation has been understudied. Previous studies have focused on
how PP2ACdc55 regulates Pds1 stability through APC inactivation, specifically during spindle
disruption (90, 91). In contrast, my findings show that in normal cell cycle conditions, PP2ACdc55
has a more prominent role in regulating Pds1 phosphorylation status rather than stability.
My findings also show that Pds1 protein levels were transiently elevated during mitosis
in cdc55-101 cells. Pds1 levels were similarly elevated in pds1-38 cdc55-101 cells, indicating
that although the protein level change is likely a result of PP2ACdc55 nuclear exclusion but not
through Pds1 C-terminal dephosphorylation. A possible explanation is that transient undetected
hyperphosphorylation at the Pds1 N-terminus affect Pds1 protein levels. This hypothesis is
supported by the presence of a Destruction Box at the N-terminus that is necessary for APCdependent ubiquitination (123). The Pds1 N-terminus also contains a predicted KEN motif which
may also affect APC recognition (249).
Alternatively, Pds1 protein levels may be controlled by PP2ACdc55 on a transcriptional or
translational level. Previous work has shown that Pds1 transcription is regulated in a cell-cycle
dependent manner, with peak mRNA levels occurring at the G1/S transition, while overproduced
Pds1 is rapidly degraded during G1 phase (116). An examination of PDS1 mRNA levels in
cdc55-101 cells would elucidate if PP2ACdc55 had an effect on transcriptional regulation of
Pds1 levels.
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2.3.2 Pds1 phosphorylation status affects spindle morphology as well as elongation rate
cdc55-101 cells show accelerated spindle elongation, and conversely the long spindles
observed in pds1-38 cells are unstable. Taken together, these findings demonstrate a link
between Pds1 phosphorylation status and spindle elongation and integrity. Since the Pds1-38
variant does not interact with Esp1, it is possible that the fragile spindle morphology is due to a
loss of Pds1-Esp1 interaction. A previous study proposed that the Pds1-Esp1 physical interaction
is an activating step for Esp1 (135). In their model, the Pds1-Esp1 interaction would cause a
conformational change that exposes the Esp1 catalytic domain (135). Without an activating step,
Esp1 spindle elongation function may be defective in pds1-38 cells.
Spindle elongation begins prior to Pds1 degradation, suggesting that Esp1 is able to
elongate spindles while bound to Pds1. Esp1’s spindle function may be mediated through
additional binding partners. Although Scc1 and Slk19 are Esp1’s only confirmed binding
partners, there are an additional 35 proteins that contain the Esp1 core recognition motif
(D/E)XXR(135). Proteins that contain the core motif include several spindle-regulating proteins,
including the microtubule motors proteins (Kip1, Cin8, Kar3), MAPs (Ase1, Stu2) and CPC
subunits (Sli15, Ipl1, and Bir1)(135).
In pds1D cells, Esp1 is not localized at the SPBs. Since Esp1 localization is controlled by
the Pds1-Esp1 localization, it can be inferred that Esp1 would be similarly absent from the SPBs
in pds1-38 cells(118). The absence of Esp1 at the SPB may result in a defect in microtubule-SPB
attachment, which may also explain the short spindle shuttling seen in pds1-38 cells. The
microtubule motor protein Kar3 and both of its binding partners (Cik1 and Vik1) are candidate
Esp1 binding partners, according to a study by Sullivan et al. (135). Vik1 is necessary for Kar3
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localization to the SPB, and also shows a cell cycle-dependent decrease in abundance. Kar3
provides inward-directed force to the spindles, and thus overexpression prevents spindle
elongation and results in permanently short spindles (190, 192). Esp1 localization to the SPB
may promote Vik1 degradation to limit Kar3 at the SPBs, or it may prevent Kar3 activity by
physically binding the Vik1-Kar3 complex.
Kip1 and Cin8 are plus end motor proteins that provide outward-directed tension to the
sister chromatids. Both proteins decline in abundance during cell cycle progression (135).
Therefore, it is possible that Esp1 promotes Kip1 and Cin8 degradation during anaphase to
inhibit spindle elongation. In this scenario, enhanced Pds1-Esp1 binding would prevent
premature spindle elongation.
An alternative explanation for accelerated spindle elongation in cdc55-101 is that Esp1 is
prematurely recruited to the nucleus and activates the FEAR pathway. This scenario is consistent
with my finding that Pds1 localization is regulated by PP2ACdc55. Pds1 showed premature
nuclear localization in cdc55-101 cells, raising the possibility that Pds1 and Esp1 form a
complex in the cytoplasm and then prematurely localize to the nucleus. Esp1 and its binding
partner, Slk19, are components of the FEAR pathway which releases Cdc14 from the nucleolus
134). Cdc14 has multiple roles in promoting spindle assembly during anaphase. Cdc14
dephosphorylates CPC component Sli15, which causes Sli15 to relocate from the kinetochore to
anaphase spindle midzone to stabilize the spindle (197). Cdc14 also dephosphorylates Cin8 and
Ase1 to activate them, which results in spindle midzone assembly during Anaphase B (250, 251).
Thus, timing of Cdc14 release may be altered in cdc55-101 cells as a result of extended Pds1
hyperphosphorylation, and early Cdc14 release would promote anaphase spindle elongation.
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2.3.3. Additional genetic interactions exist between Pds1 and Cdc55
A cross between pds1D and cdc55-101 strains revealed that the double mutant was
inviable, indicating that there are additional genetic interactions between PDS1 and CDC55. This
finding is consistent with data from Lianga et al. that showed that PP2ACdc55 directly
dephosphorylates Esp1 to inhibit it (129). In their proposed model, Pds1 and PP2ACdc55 act in
redundant pathways to inhibit Esp1 activity (129). Thus, in the absence of Pds1 and nuclear
Cdc55, nuclear Esp1 would be unregulated while cytoplasmic Esp1 would be inactivated by
cytoplasmic PP2ACdc55.
In an alternative explanation for synthetic lethality between pds1D and cdc55-101,
nuclear PP2ACdc55 may inhibit chromatid segregation in pds1D cells by acting on Scc1.
Chromatin-bound Scc1 is phosphorylated by Cdc5 to promote Esp1 recognition (252). PP2ACdc55
has been shown to protect cohesin during meiosis by dephosphorylating Rec8, the meiotic
equivalent of Scc1 (253). It is therefore possible that nuclear PP2ACdc55 has a similar role during
mitosis and dephosphorylates Scc1 to prevent Esp1 recognition. In this scenario, a loss of Pds1
would result in constitutively active Esp1, and nuclear exclusion of PP2ACdc55 would result in
enhanced recognition of Scc1 by Esp1.
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Chapter 3: A role for PP2ACdc55 in replication stress response
3.1 Introduction
DNA replication stress is one of several forms of genotoxic stress that compromises
genome integrity. Replication stress causes replication fork stalling, which in turn can cause fork
collapse and DNA damage. Genotoxic stress activates checkpoint mechanisms to arrest the cell
cycle and prevent sister chromatid segregation. Under normal conditions, chromatid segregation
requires active Esp1 to cleave cohesin and promote spindle elongation (113, 121). During
replication stress, Pds1 is stabilized to ensure continued Esp1 inhibition (113).
There are three pathways that arrest the cell cycle during replication stress: the Intra-S
checkpoint, the SAC, and Swe1-dependent M-Cdk1 inhibition (Figure 3.1, Scenarios 1-3). The
Intra-S checkpoint is the most well-studied replication stress response pathway (Figure 3.1,
Scenario 2) (223). The Intra-S checkpoint is activated by sensor kinase Mec1, which
phosphorylates and activates the effector kinase Rad53, which in turn forms a complex with
Rad9 (125). Rad53-Rad9 has multiple downstream functions, including stabilizing Pds1 by
disrupting the interaction between Pds1 and the APC binding partner Cdc20 (216). Rad53 also
inhibits M-Cdk1 activity to arrest the cell cycle (217). The Mec1 signaling cascade has a second
effector kinase, Chk1, that is activated by DNA damage, but not replication stress, that directly
phosphorylates Pds1 to prevent its ubiquitination (125). In addition to protecting cohesin, the
Intra-S checkpoint also suppresses spindle elongation (254). When DNA replication is stalled in
early S-phase, spindle elongation is inhibited in a Mec1/Rad53-dependent manner (254). When
replication is stalled in late S-phase, spindle elongation is inhibited in a Pds1-dependent manner
(254).
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Recent work from Quintana’s lab shows that the SAC protein Mad2 and the M-Cdk1
inhibitor Swe1 also contribute to replication stress response (Figure 3.1, Scenarios 1 and 3). In
Intra-S-deficient strains, Mad2 maintains sister chromatid cohesion during replication stress and
DNA damage by inhibiting APCCdc20 (Figure 3.1, Scenario 3) (218). Replication stress also
activates Swe1, which phosphorylates and inhibits M-Cdk1 (217). M-Cdk1 inhibition by Swe1 is
redundant to Rad53 (217) (Figure 3.1, Scenario 1).
A study by Liu et al. showed that cdc55D, pph21D and pph22D cells are sensitive to HU
treatment (255). Cdc55 is one of two possible B regulatory subunits of PP2A and Pph21 and
Pph22 are PP2A catalytic subunits (143). Although this study did not determine what pathway
PP2ACdc55 acts in during replication stress, they proposed that HU sensitivity was due to toxic
Swe1 accumulation, as cytoplasmic PP2ACdc55 downregulates Swe1 (255). Since Swe1 inhibits
M-Cdk1 via Y19 phosphorylation, Swe1 accumulation results in cell cycle arrest at the G2/M
transition (149). During normal cell cycle conditions, cytoplasmic PP2ACdc55 downregulates
Swe1 to suppress M-Cdk1 activity at mitotic entry (98, 103). Another potential role for
PP2ACdc55 in replication stress response is through APC inhibition. During spindle perturbation,
nuclear PP2ACdc55 promotes Pds1 stability by dephosphorylating APC components Cdc16,
Cdc23, and Cdc27 and thus inhibiting spindle elongation (90).
In this chapter, I present data that specifies where PP2ACdc55 nuclear function fits in
replication stress response relative to the known pathways. There are four possible scenarios that
nuclear PP2ACdc55 may act in during replication stress (Summarized in Figure 3.1). In Scenario 1,
PP2ACdc55 acts through the Swe1 pathway to regulate M-Cdk1 activity. In Scenario 2, PP2ACdc55
acts in the Intra-S checkpoint, either upstream or downstream of Mec1 or Rad53, to promote
Pds1 stability or inhibit mitotic-Cdk1 activity. In Scenario 3, PP2ACdc55 acts through the SAC to
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deactivate APCCdc20 to stabilize Pds1. In Scenario 4, PP2ACdc55 acts in a novel pathway to
directly inhibit sister chromatid segregation. I determined if PP2ACdc55 acts through one of the
known replication stress response and if PP2ACdc55’s activity during replication stress is Pds1dependent or -independent. In order to focus on nuclear PP2ACdc55 function, I used the cdc55101 localization mutant to exclude Cdc55 from the nucleus (154).
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Figure 3.1. Signal transduction pathways activated by replication stress (A) 1: The Intra-S
checkpoint is triggered by sensor kinase Mec1 and its binding partner Ddc2. Rad53 is an effector kinase
downstream of Mec1 which stabilizes Pds1 and inhibits CDK. 2: Swe1 dependent CDK inhibition lead
to mitotic arrest. 3: Mad2 is a key protein in SAC which inhibits APC leading to Pds1 stabilization. 4:
Unknown pathway
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3.2 Results
3.2.1 PP2ACdc55 acts independently of known pathways during replication stress
Although Liu et al. showed that cdc55D cells are sensitive to HU, they did not determine
PP2ACdc55’s function during replication stress response. I tested if PP2ACdc55 acts in one of the
known response pathways (255). Since PP2ACdc55 has acts in different pathways dependent on its
localization, manipulating Cdc55 localization allows us to focus on individual pathways.
Therefore, I used the cdc55-101 strain, which only has Cdc55 in the cytoplasm (154). To test if
nuclear PP2ACdc55 function is involved in replication stress response, I performed a serial
dilution assay with cdc55-101 cells on HU plates (Figure 3.2). At 100mM HU, cdc55D and
cdc55-101-MYC cells showed a similar growth defect (Figure 3.2, Lanes 3 and 5). I next
confirmed that the growth defect in cdc55-101-MYC cells was due to nuclear exclusion and not
an unintended consequence of the Gly43Asp mutation by using CDC55-NES and CDC55-NLS
cells on HU plates (Figure 3.2, Lanes 7-8). CDC55-NES showed a similar growth defect as
cdc55-101-MYC and cdc55D, while CDC55-NLS showed a severe growth defect (Figure 3.2,
Lanes 3, 5, 7-8). This result showed that both nuclear and cytoplasmic PP2ACdc55 are involved in
replication stress response, but most likely through different pathways.
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YPD

YPD
+ 100mM HU
1. WT
2. CDC55-MYC
3. cdc55-101-MYC
4. mec1Δ sml1Δ
5. cdc55Δ

6. CDC55-GFP
7. CDC55-GFP-NLS
8. CDC55-GFP-NES

Figure 3.2. Cells with mutations in CDC55 are sensitive to HU. Cells of the indicated genotype were
diluted in a 10-fold serial dilution and spotted on YPD plates with or without HU. Plates incubated for 2
days at 30ºC.
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To determine which pathway PP2ACdc55 acts in during replication stress, I then performed
serial dilution assays to test for synthetic growth defects in cdc55-101 cells with mutations in the
Intra-S checkpoint, SAC, and Swe1 pathways. The Intra-S checkpoint is activated by sensor
kinase Mec1 and cell cycle arrest is facilitated by effector kinase Rad53 (208). MEC1 and
RAD53 are essential genes, but inviability can be rescued by deleting SML1, which encodes a
ribonucleotide reductase inhibitor (256). Serial dilution assays were performed using mec1D
sml1D and rad53D sml1D cells, that had either CDC55-MYC or cdc55-101-MYC (Figure 3.3).
Since Intra-S deficient strains are hypersensitive to replication stress, 2.5mM HU was used for
these serial dilution assays (Figure 3.3, Lanes 1-14)(223). mec1D sml1D cdc55-101-MYC cells
showed a synthetic growth defect compared to mec1D sml1D CDC55-MYC cells (Figure 3.3,
Lane 3 compared to Lane 5). Similarly, rad53D sml1D cdc55-101 cells showed more severe HU
sensitivity compared to rad53D sml1D (Figure 3.3 Lane 7 compared to Lane 9). To confirm that
there was no unintended genetic interaction between CDC55 and SML1, sml1D cdc55-101-MYC
cells were also tested on HU plates (256). sml1D cells did not show a growth defect on HU and
there was no synthetic effect in sml1D cdc55-101-MYC cells compared to cdc55-101-MYC single
mutant (Figure 3.3, Lanes 10 and 12 compared to 14). This finding confirmed that the SML1
deletion did not contribute to the growth defect in mec1D sml1D and rad53D sml1D cells.
During MMS treatment, Mec1 also activates Chk1 kinase, which stabilizes Pds1 by
phosphorylating it (125). A previous study showed that Chk1 is not activated by replication
stress (125). I confirmed that Chk1 is not involved in HU response by performing a serial
dilution assay using chk1D cells, which only showed mild sensitivity at a comparatively high
concentration of 100mM HU (Figure 3.3, Lane 16). HU sensitivity in chk1D cdc55-101-MYC
was identical to cdc55-101-MYC, indicating that the growth defect in chk1D cdc55-101-MYC
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was solely due to Cdc55 nuclear exclusion (Figure 3.3, Lane 17 compared to 18). Taken
together, these serial dilution assays demonstrate that PP2ACdc55 acts independently from the
Mec1-dependent cascade during replication stress.
YPD

YPD
+ 2.5mM HU
1. mec1Δ sml1Δ
2. CDC55-MYC
3. mec1Δ sml1Δ CDC55-MYC
4. cdc55-101-MYC
5. mec1Δ sml1Δ cdc55-101-MYC
6. CDC55-MYC
7. rad53Δ sml1Δ CDC55-MYC
8. cdc55-101-MYC
9. rad53Δ sml1Δ CDC55-MYC
10. sml1Δ
11. CDC55-MYC
12. sml1Δ CDC55-MYC
13. cdc55-101-MYC
14. sml1Δ cdc55-101-MYC

YPD

YPD
+ 100mM HU
1. chk1Δ
2. CDC55-MYC
3. chk1Δ CDC55-MYC
4. cdc55-101-MYC
5. chk1Δ cdc55-101-MYC

Figure 3.3. cdc55-101 shows a synthetic growth defect on HU when combined with mutants in
the Mec1 pathway. Cells of the indicated genotype were diluted in a 10-fold serial dilution and spotted
on YPD plates with or without HU. Plates were incubated for 3 days at room temperature. Arrows
highlight strains with combined mutations.
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Palou et al. showed that Mad2 prevents chromatid segregation in mec1D sml1D cells in
HU and MMS treatment (217, 218). Mad2 has been well-studied for its role in arresting the cell
cycle when SAC is triggered (233). During SAC activation, PP2ACdc55 also deactivates APC by
dephosphorylating subunits Cdc16, Cdc23, and Cdc27 (90). It is therefore possible that
PP2ACdc55 acts through the SAC pathway to inactivate APCCdc20 during replication stress. To test
if PP2ACdc55 acts in SAC during replication stress, I used mad2D strains with either CDC55-MYC
or cdc55-101-MYC and performed a serial dilution assay on HU plates (233). mad2D cells were
not sensitive to HU, suggesting that SAC is dispensable for replication stress response (Figure
3.4A, Lane 1). The growth defect in mad2D cdc55-101-MYC cells was identical to cdc55-101MYC single mutant cells, indicating that the growth defect in these strains was solely due to
Cdc55 nuclear exclusion (Figure 3.4A, Lane 4 compared to Lane 5).
I then tested if PP2ACdc55 targets the APC core subunits during replication stress. Phostag analysis was used to examine phosphorylation status of APC core component Cdc16 in WT
and cdc55-101 cells (Figure 3.4B). The Phos-tag SDS-PAGE method uses a Phos-tag reagent
and Mn2+ molecules to bind and trap phosphorylated proteins, which separates phosphoisoforms
(257). The Cdc16 phosphoprotein bands were more intense in cdc55-101 cells compared to WT,
which was consistent with previous studies (Figure 3.4B, 0mM HU, WT vs. cdc55-101) (91).
However, the same number of Cdc16 phosphoprotein bands were present in untreated and HUtreated conditions for both WT and cdc55-101 cells, indicating that Cdc16 phosphorylation
status is not altered during replication stress (Figure 3.4B). I further tested if APC subunit
phosphorylation status affects replication stress response by performing serial dilution assays
with APC mutants lacking Cdk1 phosphorylation sites on core subunits (cdc16-6A, cdc27-5A,
and cdc23-A cdc27-5A cdc16-6A). None of the APC mutants showed HU sensitivity,
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demonstrating that APC subunit phosphorylation is irrelevant for replication stress response
(Figure 3.4C, Lanes 2-4). Taken together, these findings show that although PP2ACdc55 promotes
APC subunit dephosphorylation, this function is inconsequential to replication stress response.
Furthermore, my findings contradict the idea that the SAC has a critical role in replication stress
response.
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YPD
+ 25mM HU

YPD

1. mad2Δ
2. CDC55-MYC
3. mad2Δ CDC55-MYC
4. cdc55-101-MYC
5. mad2Δ cdc55-101-MYC
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WT
0

50

cdc55-101
100

0

50

100

mM HU

Cdc16-6HA

C

YPD

YPD
+100mM HU
1. WT
2. cdc16-6A
3. cdc27-5A
4. APC1 cdc23-A cdc27-5A cdc16-6A
5. mec1! sml1!

Figure 3.4. SAC-dependent APC inhibition is not a target of the replication stress response (A)
Cells of the indicated genotypes were diluted in a 10-fold serial dilution and spotted on YPD plates with
or without HU. Plates were incubated for 2 days at 30ºC. Arrows highlight strains with combined
mutations.(B) CDC16-6HA (WT) or CDC16-6HA cdc55-101 (cdc55-101) was incubated with 50mM or
100mM HU for 1 hour. Protein was extracted and precipitated by TCA. Cdc16-6HA phosphorylation
status was analyzed using 10% phos-tag acrylamide gel. Cdc16-6HA was detected using anti-HA
antibody. (C). Cells of the indicated genotypes were plated on YPD plates with HU as described in (A).
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The next replication stress response pathway that PP2ACdc55 may act in is Swe1dependent M-Cdk1 inhibition (Figure 3.1, Scenario 1) (217). Cytoplasmic PP2ACdc55
downregulates Swe1 to derepress M-Cdk1, but it is unknown if nuclear PP2ACdc55 also regulates
Swe1 (98, 103). Since PP2ACdc55 is constitutively in the cytoplasm in cdc55-101-MYC, it is
possible that HU sensitivity was due to altered M-Cdk1 regulation. I performed a serial dilution
assay using swe1D cells with or without cdc55-101-MYC on HU-containing plates. The growth
defect in cdc55-101-MYC swe1D was more severe than cdc55-101-MYC single mutant,
indicating that PP2ACdc55 and Swe1 act in separate pathways during replication stress (Figure
3.5A). Deletion of MIH1, which encodes a Swe1-counteracting phosphatase, was also tested on
HU (Figure 3.5B). The growth defect in mih1D cdc55-101-MYC was enhanced compared to
cdc55-101-MYC single mutant, further confirming that nuclear PP2ACdc55 acts in a pathway that
is separate from M-Cdk1 phospho-regulation (Figure 3.5B, Lanes 4 and 5).
In summary, nuclear PP2ACdc55 acts independently of the Intra-S Checkpoint, the SAC,
and Swe1 during replication stress response. These findings support a novel pathway for nuclear
PP2ACdc55 during replication stress (Figure 3.1, Scenario 4).
YPD
+ 25mM HU

YPD

1. swe1Δ
2. CDC55-MYC
3. swe1Δ CDC55-MYC
4. cdc55-101-MYC
5. swe1Δ cdc55-101-MYC
Cdc55

Figure 3.5. Nuclear PP2A
acts independently of M-Cdk1 inhibition in replication stress
response. Cells of the indicated genotype were diluted in a 10-fold serial dilution and spotted on YPD
plates with or without HU. Plates were incubated for 2 days at 30ºC.
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3.2.2. Cdc55 localization is not affected by replication stress
Both CDC55-NLS and CDC55-NES showed HU sensitivity, demonstrating that both
nuclear and cytoplasmic PP2ACdc55 are involved in replication stress (Figure 3.2, Lanes 7-8).
Since PP2ACdc55 function varies dependent on its localization, it was of interest to test if
replication stress affected Cdc55 localization. Cdc55-GFP localization was examined in
asynchronous cells that were subjected to HU treatment. As previously reported, untreated cells
showed Cdc55-GFP signal at the bud tip in small-budded cells (Figure 3.6, top) (258). Similar
signal patterns were observed in small-budded cells after one hour in HU. After extended HU
treatment (two and three hours), cells were arrested in metaphase and the GFP signal was diffuse
throughout the entire cell, which was similar to untreated large-budded cells (Figure 3.6,
bottom). It can therefore be concluded that Cdc55 distribution between the nucleus and
cytoplasm is not affected by replication stress.
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DIC

Cdc55-GFP

50mM HU
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Time (hr)
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Figure 3.6. Cdc55 distribution does not change in HU. Asynchronous CDC55-GFP cells in lowfluorescence media was subjected to HU treatment at 50mM or 100mM. Images were taken at the
indicated times. Orange arrow highlights bud tip localization. Blue arrow highlights bud neck localization.
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3.2.3 Sister chromatid cohesion is not affected by Cdc55 nuclear exclusion during
replication stress
I next examined the downstream effects of PP2ACdc55 nuclear exclusion on replication
stress response. Replication stress triggers cell cycle arrest with cohesed chromatids. To test if
nuclear PP2ACdc55 was necessary for maintaining chromatid cohesion, I monitored cell cycle
progression and chromatid segregation status in WT and cdc55-101 cells. Cells were
synchronized in G1 and released into media containing 100mM HU. At t=150 minutes, cdc55101 cells showed slightly accelerated cell cycle progression compared to WT (Figure 3.7A).
Chromatid segregation was also examined in propidium iodide-stained cells by microscopy and
cells were categorized as having fully segregated chromatids, unsegregated chromatids, or a
stretched phenotype that showed a single fluorescing structure stretched across both cell bodies
(Figure 3.7B, Bottom). Neither WT nor cdc55-101 cells showed significant chromatid
segregation, with 6% of WT cells and 7% of cdc55-101 cells having fully segregated sister
chromatids by t=180 minutes (Figure 3.7B). There was a striking difference in the number of
cells exhibiting the stretched phenotype. At t=150 and t=180 minutes, 39% and 38% of cdc55101 cells showed stretched staining, respectively. In contrast, 16% and 18% of WT cells had the
stretched phenotype at the same respective time points (Figure 3.7B, WT t=150 and t=180). To
test if the stretched staining represented incomplete chromatid segregation, centromere
separation was examined using CenIV-GFP, which showed fluorescent dots localized to the
centromere. Cells were categorized based on separation of GFP dots. At 100mM HU, neither
WT nor cdc55-101 showed a significant number of cells with fully segregated sister chromatids
(Figure 3.8). This result demonstrates that the stretched propidium iodide staining seen in Figure
3.7 is not due to cohesin cleavage.
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Figure 3.7. Neither WT nor cdc55-101 cells showed sister chromatid segregation at 100mM HU.
A) PDS1-HA (WT) or PDS1-HA cdc55-101 (cdc55-101) cells were arrested in G1 with alpha factor and
released into YPD+100mM HU. Samples were taken at the indicated time points. Cell cycle status was
determined by FACS analysis. B) (Top) Sister chromatid segregation status of samples obtained in (A)
was analyzed by fluorescence microscopy. Cells were counted and categorized based on status.
Blue=unsegregated; Red=stretched staining pattern; Green=fully segregated. Representative images
of cells of each category are shown (Bottom)
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Figure 3.8. Sister chromatids do not segregate in either WT or cdc55-101 in 100mM HU. (A) CDC55
promURA::tetR::GFP CenIV::tetOx448 (WT) or cdc55-101 promURA::tetR::GFP CenIV::tetOx448
(cdc55-101) cells were arrested in G1 by alpha factor and released into 100mM HU. GFP dots were
counted per cell at the indicated time points. A total of 100 cells were counted and the percentage of the
cells for each category is shown. Blue indicates cells with1 dot, Red indicates cells with 2 adjacent dots,
Green indicates cells with 2 separated dots and Purple indicates cells with 3 or more dots. (B)
Representative images at 120 minutes after the release are shown on the right.
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3.2.4 Pds1 phospho-regulation by PP2ACdc55 during replication stress
Pds1 is a target in several replication stress response pathways, and it was of interest to
examine if nuclear PP2ACdc55 regulates Pds1 during replication stress. To examine Pds1 protein
in replication stress conditions, I compared WT and cdc55-101 cells in a time course with
100mM HU and monitored Pds1 protein level and phosphorylation status. Pds1 protein level was
slightly reduced in cdc55-101 cells compared to WT cells at 180 and 210 minutes after release
into HU, suggesting that PP2ACdc55 may marginally affect Pds1 stability after prolonged HU
treatment (Figure 3.9A). Pds1 was also hyperphosphorylated in cdc55-101 cells compared to WT
at t=60 to t=150 min, which was determined by quantifying the band intensity ratio between
Pds1 upper and lower band at each time point (Figure 3.9B). To identify the specific time point
where Pds1 was hyperphosphorylated in cdc55-101, a time course in 100mM HU was performed
with 15-minute intervals for 90 minutes. Pds1 hyperphosphorylation was first present at 30
minutes after release and continued through the remainder of the time course (Figure 3.10). The
30-minute time point is also when Pds1 first starts to accumulate, demonstrating that altered
Pds1 phospho-regulation by nuclear PP2ACdc55 occurs immediately after Pds1 translation
(Figure 3.10). The observation that PP2ACdc55 had a more prominent effect on Pds1
phosphorylation than on Pds1 stability is consistent with my findings in normal cell cycle
conditions in Chapter 2, and further suggests that PP2ACdc55 does not dephosphorylate Pds1
specifically during replication stress. In contrast, findings from Chapters 2 and 3 suggest that
Pds1 dephosphorylation is a normal function of PP2ACdc55 that appears to be enhanced during
replication stress due to extended S-phase.
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Figure 3.9. Pds1 is transiently hyperphosphorylated in cdc55-101 at 100mM HU. A) PDS1-HA
(WT) or PDS1-HA cdc55-101 (cdc55-101) cells were arrested in G1 phase with alpha factor, then
released into YPD media containing 100mM HU. Alpha factor was added to the cultures at 80 minutes
after release. Cells were collected for Western blot at the indicated times. Pgk1 was used as a loading
control. (B) Ratio of top band intensity to bottom band intensity were calculated for three independent
experiments. Error bars represent the SEM.
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Figure 3.10. Pds1 is hyperphosphorylated in cdc55-101 cells at 100mM HU immediately following
accumulation. PDS1-HA (WT) or PDS1-HA cdc55-101 (cdc55-101) cells were arrested in G1 phase
by alpha factor and released into YPD media containing 100mM HU. Cells were collected at 15-minute
intervals for Western blot. Pgk1 was used as a loading control.
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The presence of synthetic growth defects in mec1D sml1D cdc55-101 cells suggested that
nuclear PP2ACdc55 and Mec1 act independently of each other (Figure 3.3). I then sought to
examine Pds1 regulation without interference from the Intra-S checkpoint. To limit Mec1
activity, the time course from Figure 3.9 was repeated using lower concentration of HU at
50mM. Pds1 was transiently hyperphosphorylated in cdc55-101 cells. Pds1
hyperphosphorylation in cdc55-101 was most apparent at t=60 to t=120 minutes (Figure 3.11AB). Taken with results in 100mM HU treatment, these findings show that Pds1
hyperphosphorylation in cdc55-101 cells is HU dose-dependent and independent of Mec1.
Since Pds1 is a Cdk1 substrate, I tested if Cdk1 activity was altered by PP2ACdc55 nuclear
exclusion. HU sensitivity in CDC55-NLS cells indicates that that cytoplasmic PP2ACdc55 is
involved in replication stress. Cytoplasmic PP2ACdc55 regulate Cdk1 activity through the Swe1
pathway during replication stress (Figure 3.1 Scenario 1, and Figure 3.2). Swe1 inhibits M-Cdk1
by phosphorylating it at residue Y19 (149). Cytoplasmic PP2ACdc55 was previously shown to
downregulate Swe1, and therefore it is possible that Swe1 is downregulated in cdc55-101 cells
(103). Unexpectedly, Cdk1-Y19 phosphorylation was elevated in HU-treated cdc55-101 cells,
indicating that Cdk1 is downregulated in cdc55-101 cells during replication stress (Figure
3.11A).
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Figure 3.11. Pds1 hyperphosphorylation in HU treatment is dose-dependent. (A) PDS1-HA (WT)
or PDS1-HA cdc55-101 (cdc55-101) cells were arrested in G1 phase with alpha factor, then released
into YPD media containing 50mM HU, as described in Figure 5.9. Pgk1 was used as a loading control.
(B) Ratio of top band intensity to bottom band intensity were calculated for three independent
experiments. Error bars represent the SEM
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To confirm that Pds1 hyperphosphorylation was a result of PP2ACdc55 acting directly on
Pds1 rather than through a Swe1/Cdk1 pathway, I examined Pds1 phosphorylation status in
cdc55D swe1D cells. swe1D and cdc55D swe1D cells were treated with HU and Pds1 protein was
immunoprecipitated and separated by phos-tag SDS-PAGE. Pds1 showed more
hyperphosphorylation bands in cdc55D swe1D cells compared to swe1D cells (Figure 3.12). This
result supports the hypothesis that nuclear PP2ACdc55 promotes Pds1 dephosphorylation

swe1Δ cdc55Δ

swe1Δ

independently of Swe1-dependent Cdk1 regulation.

Pds1

Figure 3.12. Pds1 is hyperphosphorylated in cdc55 Δ cells in HU. PDS1-HA swe1Δ (swe1Δ) or
PDS1-HA swe1Δ cdc55Δ (swe1Δ cdc55Δ ) cells were arrested in G1 phase with alpha factor, then
released into YPD media containing 50mM HU, and collected after one hour. Protein samples were
analyzed on a phos-tag acrylamide gel using anti-HA antibody.
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I next confirmed that PP2A-dependent Pds1 phospho-regulation is specific to the B
regulatory subunit Cdc55. Rts1 is the only other PP2A regulatory subunit in budding yeast (143).
To test if PP2ARts1 regulates Pds1 phosphorylation status, rts1D cells were treated with HU in a
time course and Pds1 protein was monitored. There was no apparent difference in Pds1
phosphorylation status in rts1D cells compared to WT, confirming that the Pds1
hyperphosphorylation observed in cdc55-101 was due specifically to a loss of Cdc55 nuclear
function (Figure 3.13).
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Figure 3.13. Pds1 phosphorylation status is not altered in rts1𝛥 cells in HU treatment.
PDS1-HA (WT) or PDS1-HA rts1𝛥 (rts1𝛥) cells were arrested in G1 phase with alpha factor,
then released into YPD media containing 50mM HU, as described in Figure 3.11 Pgk1 was
used as a loading control.
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Since Cdc55 nuclear exclusion correlates with Pds1 hyperphosphorylation, I expected
that CDC55 overexpression would lead to Pds1 hypophosphorylation. Pds1 phosphorylation
status was monitored in HU-treated GAL-CDC55 cells in glucose or galactose. At t=90 minutes,
galactose-treated cells had more unphosphorylated Pds1 compared to glucose-treated cells,
which supports a scenario where PP2ACdc55 dephosphorylates Pds1 (Figure 3.14). There was no
apparent difference in the ratio of hyperphosphorylated-to-unphosphorylated Pds1 after t=120
minutes (Figure 3.14). This result may indicate that Cdc55 localization has a more prominent
effect on Pds1 phosphorylation status than overall Cdc55 protein level. The presence of Pds1
phosphoprotein during CDC55 overexpression may also indicate that the full PP2A complex
needs to be overexpressed for Pds1 dephosphorylation.
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Figure 3.14. Pds1 phosphorylation status is unchanged after overexpressing CDC55 in HU.
GAL-CDC55-HA PDS1-18XMYC cells were grown in YPR and arrested in G1 by alpha factor. Cells
were released in either YPD or YPG containing 50mM HU. Samples were collected at the indicated
times. Pgk1 is shown as a loading control.
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3.2.5 PP2ACdc55 phospho-regulation of Pds1 is specific to Cdk1 sites
Next, I sought to identify which Pds1 phosphorylation sites were regulated by PP2ACdc55
during replication stress. I expected that PP2ACdc55 targets the five Cdk1 consensus motifs on
Pds1 (T27, S71, S277, S292, T304), which would be consistent with findings presented in
Chapter 2 as well as a previous study by Godfrey et al. (20). However, since Pds1
hyperphosphorylation was enhanced in cdc55-101 cells compared to normal cell cycle
conditions, I considered if PP2ACdc55 targeted different or additional Pds1 sites during replication
stress (Figures 3.9 and 3.11 compared to Figure 2.1).
I first focused on the three C-terminal sites as these have a known function in regulating
Pds1-Esp1 binding (118). To test if the Pds1 C-terminal phosphorylation sites are affected during
replication stress, I treated pds1-38 cells with HU. The pds1-38 phosphorylation mutant contains
S/TàA mutations at the three C-terminal Cdk1 sites (S277, S292, T304) (118). To test if the
Pds1 C-terminus was affected by PP2ACdc55, I constructed a pds1-38 cdc55-101 double mutant
strain. pds1-38 and pds1-38 cdc55-101 cells were subjected to a time course in 50mM HU. Pds1
phosphorylation was abolished in the pds1-38 single mutant (Figure 3.15). A faint
phosphoprotein band was present in pds1-38 cdc55-101 cells, suggesting that PP2ACdc55
regulates additional Pds1 phosphorylation sites (Figure 3.15). Since there are two remaining
Cdk1 sites on Pds1 (T27, S71), I then performed a time course in HU using pds1-5A, which
contains an S/TàA mutation in all five Cdk1 consensus sites (248). Pds1 phosphorylation was
fully abolished in both pds1-5A and pds1-5A cdc55-101 (Figure 3.16A). This result suggests that
PP2ACdc55-dependent Pds1 phospho-regulation is limited to Cdk1 consensus sites.
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Figure 3.15. Pds1 shows faint phosphoprotein band in HU-treated pds1-38 cdc55-101. pds1-383HA and cdc55-101 pds1-38-3HA cells were arrested in G1 with alpha factor and released into
YPD+50mM HU. Samples were taken at the indicated times for western blot. Alpha factor was added to
cultures at t=80 minutes.
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During genotoxic stress, Pds1 phosphorylation status is also regulated by Chk1, which is
a second effector kinase activated by Mec1 (125, 126, 209). Chk1 stabilizes Pds1 by
phosphorylating it at up to nine sites, which are distinct from the Cdk1 phosphorylation sites
(125). Since pds1-5A did not show any hyperphosphorylation, it can be concluded that Chk1 is
not activated at 50mM HU (Figure 3.16A). I then tested if Chk1 contributed to Pds1
hyperphosphorylation at a higher concentration of HU, that may induce a more robust Mec1dependent response. I repeated the time course with pds1-5A and pds1-5A cdc55-101 in 100mM
HU and neither strains showed a Pds1 hyperphosphorylation band, confirming that Chk1 is not
activated at 100mM HU (Figure 3.16B). This result further supports a role for nuclear PP2ACdc55
that is separate from the Mec1-signalling pathway during replication stress and confirms that
PP2ACdc55 only dephosphorylates Pds1 at the Cdk1 consensus sites.
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Figure 3.16. Pds1 phosphorylation is abolished in pds1-5A cdc55-101. A) pds1-5A-3HA and pds15A-3HA cdc55-101 cells were arrested in G1 with alpha factor and released into YPD+50mM HU.
Samples were taken at the indicated times for western blot. Alpha factor was added to cultures at t=80
minutes. Pgk1 is shown as a loading control. (B) A time course described in (A) was performed using
100mM HU.
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3.2.6 Pds1 hyperphosphorylation corresponds to accelerated spindle elongation
In normal cell cycle conditions, Pds1 hyperphosphorylation correlated with accelerated
spindle elongation in cdc55-101 cells, as discussed in Chapter 2. I tested if similar pattern was
present during replication stress by using TUB1-GFP cells with either CDC55 or cdc55-101.
Cells were arrested in G1 and released into 50mM HU and spindles were examined by
fluorescence microscopy. There were fewer cdc55-101 cells with short spindles compared to WT
at t=90 and t=120 minutes (68.6% and 71.3% in WT compared to 48.3% and 46.7% in cdc55101) (Figure 3.17). cdc55-101 cells started showing long spindles at t=90 minutes, while WT
cells first exhibited long spindles at t=120 minutes (Figure 3.17). Pds1 hyperphosphorylation in
cdc55-101 was most pronounced at time points with long spindles (Figure 3.11 and Figure 3.17,
t=90 and 120 minutes). This result reinforces findings in normal cell cycle conditions that show a
link between Pds1 phosphorylation status and spindle elongation, as presented in Chapter 2.
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Figure 3.17. cdc55-101 cells show altered spindle dynamics at 50mM HU. (A) CDC55 TUB1-GFP
(WT) and cdc55-101 TUB1-GFP (cdc55-101) cells were grown in synthetic complete media, arrested
in G1 by alpha factor, and released into media containing 50mM HU. Samples were taken at the
indicated times and examined by fluorescence microscopy. Alpha factor was added again at 80 minutes
after release. Cells exhibiting short spindles (Left) or long spindles (Middle) were counted at each time
point. 100 cells were counted at each time point. Graphs represent average of three independent
experiments. Error bars represent SEM. Blue=WT; Red=cdc55-101. (B) Representative images from
t=90 are shown (Right). Images were enhanced to show fluorescent signal.
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Spindle elongation requires Esp1, which is positioned at the spindle and SPBs by Pds1
(121, 131). Esp1 nuclear recruitment is dependent on Pds1 C-terminal phosphorylation (118). I
then sought to test if Pds1 C-terminal phosphorylation status affected spindle elongation during
replication stress by using HU-treated TUB1-GFP cells with either WT PDS1 or pds1-38. There
were fewer pds1-38 cells with short spindles compared to WT beginning at t=150 minutes
(30.7% in pds1-38 compared to 54.0% in WT) (Figure 3.18A). At t=150, 14.7% of pds1-38 cells
had long spindles, compared to 2% of WT cells (Figure 3.18A). The number of pds1-38 cells
with long spindles decreased after t=150 (12.3% at t=180 and 3.0% at t=210) (Figure 3.18A).
Therefore, pds1-38 cells showed fewer short spindles without corresponding increase in the
number of cells with long spindles, which suggests that pds1-38 cells initially undergo rapid
spindle elongation, but long spindles do not stably elongate. Similar to findings in normal cell
cycle conditions, spindles in pds1-38 cells were frequently nonlinear when fully elongated,
which may be a result of a defect at the SPBs (Figure 3.18B).
Spindle elongation timing in cells with hyper- and hypophosphorylated Pds1 showed the
same trends in HU as in normal cell cycle conditions indicating that spindle suppression by Pds1
dephosphorylation is not specific to replication stress response (Figures 2.4 and 2.6 compared to
Figures 3.17 and 3.18). Thus, it is possible that PP2ACdc55’s role in replication stress response is
Pds1-independent.
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Figure 3.18. Spindle elongation rates are altered in pds1-38 cells at 50mM HU. (A) PDS1 TUB1GFP (WT) and pds1-38 TUB1-GFP (cdc55-101) cells were grown in synthetic complete media, arrested
in G1 by alpha factor, and released into media containing 50mM HU. Samples were taken at the
indicated times and examined by fluorescence microscopy. Alpha factor was added again at 80 minutes
after release. Cells exhibiting short spindles (Top Left) or long spindles (Top Right) were counted at
each time point. 100 cells were counted at each time point. Graphs represent average of three
independent experiments. Error bars represent SEM. Blue=WT; Orange=pds1-38. (B) Representative
images from t=150 are shown (Right). Images were enhanced to show fluorescent signal (Top). Area in
dashed box enlarged to show morphology (Bottom).
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3.2.7 Pds1 phosphorylation mutants are not significantly sensitive to HU
Cdc55 nuclear exclusion caused Pds1 hyperphosphorylation and accelerated spindle
elongation, but it is unclear if Pds1 phosphorylation status is related to HU sensitivity in cdc55101 cells. To test if Pds1 phosphorylation status affects viability in HU, I performed a serial
dilution assay using pds1-38 and pds1-5A cells. Neither pds1-38 nor pds1-5A showed HU
sensitivity with WT CDC55 (Figure 3.19, Lanes 2 and 5). Combining pds1-38 and cdc55-101
mutations did not result in a noticeable synthetic effect (Figure 3.19, Lanes 3-4). However,
combining pds1-5A with cdc55-101 resulted in a synthetic growth defect (Figure 3.19, Lanes 3,
5, and 6). This synthetic growth defect may indicate that Pds1 N-terminal phosphorylation is
necessary for replication stress response. Furthermore, this synthetic growth defect suggests that
PP2ACdc55 and Pds1 N-terminal phosphoregulation are involved in separate pathways during
replication stress conditions. This finding supports a scenario where PP2ACdc55’s role in
replication stress response is Pds1-independent.

YPD

YPD +
100mM HU
1. CDC55-MYC
2. pds1-38 CDC55-MYC
3. cdc55-101-MYC
4. pds1-38 cdc55-101-MYC
5. pds1-5A CDC55-MYC
6. pds1-5A cdc55-101-MYC

Figure 3.19. Pds1 phosphorylation mutants are not sensitive to HU. Cells of the indicated genotype
were diluted in a 10-fold serial dilution and spotted on YPD plates with or without HU. Plates were
incubated for 2 days at 30ºC.
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3.3 Discussion
3.3.1 PP2ACdc55 likely acts independently of known replication stress response pathways
A prior study showed that PP2ACdc55 has a function in replication stress response but it
was unknown what pathway it acts through (255). Since PP2ACdc55 has functional interactions
with both Swe1 and the APC, I hypothesized that PP2ACdc55 would act through one of these two
pathways (90, 91, 103). Contrary to this, my findings support a scenario where nuclear
PP2ACdc55 acts in a novel pathway independent of the three known pathways. It remains possible
that nuclear PP2ACdc55 has a role in the Intra-S checkpoint acts downstream of Mec1 in a branch
separate from Rad53. Future directions for this study may focus on determining if PP2A
phosphatase activity levels are altered during replication stress.
My findings suggest that both nuclear and cytoplasmic PP2ACdc55 are involved in the
replication stress response, most likely through distinct pathways. Therefore, it is possible that
although nuclear PP2ACdc55 is independent of Swe1, cytoplasmic PP2ACdc55 may act through
Swe1 to regulate cell cycle progression. This scenario is supported by the observation that during
replication stress, Cdk1-Y19 phosphorylation levels were elevated in cdc55-101 cells, which is
inconsistent with previous work that proposed that cytoplasmic PP2ACdc55 downregulates Swe1
to prevent Cdk1-inhibitory phosphorylation (103). Thus, elevated Cdk1-Y19 phosphorylation
may indicate that Swe1 regulation by cytoplasmic PP2ACdc55 is altered by replication stress.
CDC55-NLS cells are more sensitive to HU than either cdc55D or CDC55-NES, suggesting that
that nuclear and cytoplasmic PP2ACdc55 act in distinct pathways during replication stress. A
potential explanation for CDC55-NLS cells’ hypersensitivity to HU is that cytoplasmic Swe1 is
stabilized, as cytoplasmic PP2ACdc55 promotes Swe1 degradation (103). The CDC55-NLS strain
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would also have an excess of nuclear PP2ACdc55, which dephosphorylates and inhibits Esp1
(129).Thus, the CDC55-NLS may undergo a robust cell cycle block during replication stress.
Findings presented in this thesis also contradict a recent study that showed a role for SAC
in HU response (218). While my findings recapitulate previous studies that showed PP2ACdc55
deactivates the APC, it was not specific to replication stress response and APC
hypophosphorylation had no consequences on HU sensitivity (90). Although PP2ACdc55dependent APC inhibition maintains genome integrity, this function of PP2ACdc55 does not
appear to have any significant effect during replication stress. This contradiction suggests that
there may be separate pathways for PP2ACdc55 regulation during SAC and replication stress
response.

3.3.2 PP2ACdc55 may have a Pds1-independent function during replication stress
During replication stress, several pathways converge on Pds1 to stabilize it and arrest the
cell cycle. Since nuclear PP2ACdc55 stabilizes Pds1 during spindle disruption, I expected that
Pds1 would be unstable in cdc55-101 cells during replication stress (90). In contrast, my findings
show that nuclear PP2ACdc55 does not have a significant effect on Pds1 stability but has a more
prominent effect on Pds1 phosphorylation during replication stress. This was further confirmed
by observations that PP2ACdc55 nuclear exclusion did not have an obvious effect on chromatid
segregation. Pds1 was similarly hyperphosphorylated in cdc55-101 cells in normal cell cycle
conditions, as presented in Chapter 2. Therefore, Pds1 phospho-regulation by PP2ACdc55 is not a
specific effect of the replication stress response, which supports the idea of PP2ACdc55 having a
Pds1-independent function during replication stress. A Pds1-independent function for PP2ACdc55
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is also supported by my finding that Pds1 phosphorylation mutants did not reverse HU sensitivity
in cdc55-101 cells.
A potential explanation for HU-sensitivity in cdc55-101 cells is that nuclear PP2ACdc55
may directly inhibits Esp1, independently of its function in dephosphorylating Pds1. Lianga et al.
showed that Esp1 is deactivated by PP2ACdc55-dependent dephosphorylation (129). This scenario
would also be consistent with my findings that pds1D cdc55-101 cells are inviable, as presented
in Chapter 2. Thus, in a cdc55-101 background, cytoplasmic Esp1 is dephosphorylated by
PP2ACdc55 and is deactivated. In this scenario, Esp1 would be inefficiently localized to the
nucleus, but its protease and spindle functions would be uninhibited, leading to genomic
instability.
Since neither pds1-38 nor pds1-5A show hyperphosphorylation when combined with
cdc55-101, it can be concluded that PP2ACdc55 dephosphorylation is specific to Cdk1 consensus
sites. This specificity is consistent with PP2ACdc55’s role as a Cdk1-counteracting phosphatase
(20). The presence of a Pds1 phosphoprotein band in pds1-38 cdc55-101 cells may suggest that
the Pds1 N-terminus is only phosphorylated during replication stress conditions. Alternatively, it
may also indicate that the Pds1 N-terminus is phosphorylated transiently during normal cell
cycle conditions and this phosphorylation is only detectable when the cell cycle is slowed down
by HU. A function for Pds1 N-terminal phosphorylation is currently unknown. Since Pds1
contains a predicted NLS at the Cdk1 consensus site S71, phosphorylation at the N-terminus may
control Pds1 localization (124). Pds1 N-terminal hyperphosphorylation may explain enhanced
Pds1 nuclear localization observed in cdc55-101 cells in Chapter 2.
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Chapter 4: PP2ACdc55 and Cdc6
4.1 Introduction
Although PP2ACdc55 has mostly been studied for its function in mitosis, there is also
evidence that the regulatory subunit Cdc55 interacts with Cdc6, a replication protein (88, 89).
Cdc6 is an essential component of the pre-RC that assembles at the origin of replication in late
G1 phase (46). After origin firing, Cdc6 is ubiquitinated by SCFCdc4 and rapidly degraded (46,
76). SCFCdc4 recognition is dependent on Cdc6 phosphorylation by two kinases: first, priming
phosphorylation is carried out by Cdk1, and second, Mck1 phosphorylates an adjacent site to
create a phospho-degron (76, 80, 81). Mutating sites necessary for SCFCdc4 recognition leads to
Cdc6 stabilization and mitotic arrest (259). A Cdc6-T39A-T368A variant contains point
mutations at two Mck1 consensus sites and is therefore stabilized, and causes mitotic arrest when
overexpressed (80, 81). Similarly, a study by Boronat et al. showed that overexpressing Cdc6S372A, which contains a mutation in a Cdk1 site at the C-terminal phospho-degron, results in
mitotic arrest (89). Boronat et al. further showed that mitotic arrest resulting from Cdc6
stabilization is suppressed in cdc55D cells, and that Cdc6 and Cdc55 physically interact
specifically during mitosis (89). These findings led to a proposed model where Cdc6 recruits
Cdc55 and targets PP2ACdc55 to deactivate APCCdc20, resulting in metaphase arrest (89).
Cdc6 degradation is one of several mechanisms to disassemble the Pre-RC and limit
DNA replication to once per cell cycle (74, 80, 84). Other mechanisms that prevent DNA rereplication include Orc2 and Orc6 phosphorylation, Orc6-Clb5 binding, and Mcm2-7 nuclear
export (72, 74). Mutations that promote DNA re-replication include: ORC2-ps and ORC6-ps,
which lack Cdk1 phosphorylation sites, ORC6-rxl, which does not bind Clb5, MCM7-NLS,
which forces the MCM complex to remain in the nucleus (72, 74). Since mechanisms to prevent
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DNA re-replication overlap, individual mutations do not compromise DNA replication control
(75). However, combining mutations in Pre-RC disassembly mechanisms causes DNA rereplication and triggers the Mec1-dependent DNA damage response pathway to arrest the cell
cycle (74, 75).
Nuclear PP2ACdc55 regulates mitotic progression, so it was of interest to test if nuclear
PP2ACdc55 promotes mitotic arrest during Cdc6 stabilization. In this chapter, show that mitotic
arrest caused by Cdc6 overexpression is dependent on nuclear PP2ACdc55 function. I also sought
to test if the functional relationship between Cdc6 and Cdc55 affected DNA replication and
inhibition of DNA re-replication, as these two processes are influenced Cdc6 protein levels. My
findings show that nuclear exclusion of PP2ACdc55 is associated with an S-phase entry delay,
suggesting that it has an uncharacterized role in DNA replication initiation.
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4.2 PP2ACdc55 and Cdc6: Results
4.2.1 cdc55-101 mutation rescues mitotic arrest in Cdc6-overexpressing cells
According to Boronat et al.’s model, overexpression of stabilized Cdc6 results in a
Cdc55-dependent mitotic arrest (89). To confirm the proposed genetic interaction between Cdc6
and Cdc55, I performed a serial dilution assay with GAL-CDC6-T39A-T368A cells that had
either CDC55-MYC or cdc55-101-MYC. GAL-CDC6-T39A-T368A cells with CDC55-MYC
showed a growth defect on galactose plates (Figure 4.1A, Lanes 3, 4, and 7). In contrast, induced
GAL-CDC6-T39A-T368A cdc55-101-MYC cells did not show a growth defect. (Figure 4.1A,
Lane 8). This rescue is consistent with Boronat’s proposal that Cdc6-dependent mitotic arrest
requires Cdc55 (89). I next tested if the growth defect in GAL-CDC6-T39A-T368A cells is a
result of PP2ACdc55’s function in the SAC pathway. During SAC activation, PP2ACdc55 arrests the
cell cycle by deactivating APCCdc20 (90). I performed a serial dilution assay using the spindledisrupting agent benomyl to activate SAC (Figure 4.1B). cdc55-101-MYC cells were sensitive to
benomyl, consistent with previous studies that showed a role for nuclear PP2ACdc55 in SAC
(Figure 4.1B, Lane 2) (90). GAL-CDC6-T39A-T368A cells showed moderate benomyl sensitivity
on galactose plates (Figure 4.1B, Lane 3). GAL-CDC6-T39A-T368A cdc55-101-MYC cells
showed the same growth defect on benomyl as cdc55-101 cells, and furthermore, they showed
the same growth defect with or without galactose (Figure 4.1B, Lanes 4-5). Based on these
findings, it is possible that Cdc6 overexpression may trigger the SAC, but it is unclear if
PP2ACdc55 is in the same pathway.
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Figure 4.1. cdc55-101 rescues growth defect in induced GAL-CDC6-T39A-T368A cells. Cells of
the indicated genotype were diluted in a 10-fold serial dilution and spotted on glucose or galactose
plates. (B) Cells of the indicated genotype were diluted in a 10-fold serial dilution and spotted on
glucose or galactose with or without 15μg/mL benomyl. Blue lines highlight strains with WT CDC55 or
cdc55-101.
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Based on Boronat et al.’s model, I hypothesized that the growth defect in galactosetreated GAL-CDC6-T39A-T368A cells is a result of mitotic arrest, and the rescue in GAL-CDC6T39A-T368A cdc55-101-MYC cells is due to mitotic arrest bypass. To test this model, I examined
cell cycle profile by flow cytometry. GAL-CDC6-T39A-T368A CDC55-MYC cells showed a
higher 2C DNA peak in galactose compared to GAL-CDC6-T39A-T368A cdc55-101-MYC cells,
which supports the premise that overexpressing stabilized Cdc6 resulted in mitotic arrest that is
dependent on nuclear Cdc55 (Figure 4.2). I further examined chromatid segregation status in
GAL-CDC6-T39A-T368A cells with or without cdc55-101-MYC. 56% of induced GAL-CDC6T39A-T368A CDC55-MYC cells were arrested in mitosis with unsegregated chromatids,
compared to 18% of GAL-CDC6-T39A-T368A cdc55-101-MYC cells (Figure 4.3A, yellow bars).
Induced GAL-CDC6-T39A-T368A CDC55-MYC cells also had elongated buds, consistent with
previous findings (Figure 4.3B) (81). In comparison, GAL-CDC6-T39A-T368A cdc55-101-MYC
cells showed normal morphology (Figure 4.3B). These findings further support the idea that
nuclear PP2ACdc55 promotes mitotic arrest during Cdc6 stabilization, consistent with the model
proposed by Boronat et al. (89).
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Figure 4.2 cdc55-101 cells bypass mitotic arrest when Cdc6 is overexpressed and stabilized.
GAL-CDC6-T39A-T368A CDC55-MYC or GAL-CDC6-T39A-T368A cdc55-101-MYC cells were grown
in raffinose-containing media and treated with either glucose or galactose for 2 hours. Cells were
stained with propidium iodide and DNA content was determined by flow cytometry. 1C and 2C DNA
content peaks are marked.
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Figure 4.3. cdc55-101 cells show chromatid segregation when CDC6-T39A-T368A is
overexpressed. A) Propidium iodide-stained cells from Figure 4.2 were examined by fluorescence
microscopy and categorized budding and chromatid segregation status (Blue=Unbudded,
Orange=Small Budded; Gray=Large bud & segregated chromatids, Yellow=Large bud & unsegregated
chromatids). (B) Representative images are shown.
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4.2.2 No physical interaction between Cdc6 and Cdc55 is detected
Boronat et al.’s model depends on a physical interaction between Cdc6 and Cdc55 which
recruits PP2ACdc55 (89). To confirm that Cdc6 and Cdc55 interact, I performed a yeast twohybrid assay (Y2H) using the L40 yeast strain. L40 cells were co-transformed with plasmids
containing a LexA DNA binding vector and a GAL4 Activating Domain vector and treated with
X-Gal substrate to examine a color change. Cells co-transformed with plasmids containing Cdc6
and Cdc55 did not show any detectable color change (Figure 4.4A, Left). For comparison, cells
co-transformed with plasmids containing Cdc6 and the SCFCdc4 component Cdc4 yielded a color
change, while cells co-transformed with Cdc6 and an empty plasmid showed no color change
(Figure 4.4A, Middle and Right) (76). Based on these results, it is inconclusive Cdc55 and Cdc6
interact in vivo.
I next tested if stabilized Cdc6 interacts with Cdc55 by performing co-IP using CDC6T39A-T368A-prA CDC55-MYC cells (Figure 4.3B). Purified CDC6-T39A-T368A-prA was bound
to the same level of Cdc55 protein as the single-tagged CDC55-MYC control (Figure 4.4B). This
result shows that there is no detectable interaction between Cdc55 and stabilized Cdc6. Taken
together, these findings contradict the idea that Cdc6 and Cdc55 physically interact (89).
However, it is still possible that a Cdc6-Cdc55 interaction is too transient to detect by yeast twohybrid or co-IP.
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Figure 4.4. Cdc55 and Cdc6 do not show a detectable physical interaction. (A) Yeast 2-hybrid
assay was performed using L40 yeast strain transformed with LexA Binding plasmid containing CDC6
or CDC6-C-terminus. Cells were co-transformed with either a GAL4 Activating Domain plasmid
containing CDC55 or CDC4 (Left) or an empty vector (Right). (B) Cells of the indicated genotype were
grown asynchronously and Cdc6-Cdc55 physical interaction was tested by Co-IP. Cdc6-prA was
isolated from cell lysate using anti-IgG beads and Cdc55-MYC protein was detected by western blot.
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4.2.2 PP2ACdc55 and DNA re-replication
Cdc6 degradation is one of several mechanisms to disassemble the Pre-RC after origin
firing and prevent DNA re-replication (74). Other overlapping mechanisms that prevent DNA rereplication include Orc2 and Orc6 phosphorylation, Orc6-Clb5 binding, and Mcm2-7 nuclear
export (72, 74, 75). CDC6DNT, ORC6-rxl, ps and MCM7-NLS are mutations that cause DNA rereplication in a synergistic manner (74, 75). If nuclear PP2ACdc55 arrests the cell cycle when
Cdc6 is stabilized, this function may have consequences in DNA re-replication response.
To test if Cdc55 nuclear exclusion affects the cell cycle response to DNA re-replication, I
performed a serial dilution assay using the re-replicating strain ORC6-rxl, ps GAL-CDC6DNT
with either CDC55-MYC or cdc55-101-MYC. OR6-rxl,ps GAL-CDC6DNT cdc55-101-MYC
showed a synthetic growth defect on galactose (Figure 4.5, Lanes 5-6). A similar growth defect
was seen when combining OR6-rxl,ps GAL-CDC6DNT MCM7-NLS mutations with cdc55-101MYC (Figure 4.5, Lanes 8-9).
Glucose

Galactose
1. WT
2. CDC55-MYC
3. cdc55-101-MYC
4. ORC6-rxl,ps GAL-CDC6ΔNT
5. ORC6-rxl,ps GAL-CDC6ΔNT CDC55-MYC
6. ORC6-rxl,ps GAL-CDC6ΔNT cdc55-101-MYC
7. ORC6-rxl,ps GAL-CDC6ΔNT MCM7-NLS
8. ORC6-rxl,ps GAL-CDC6ΔNT MCM7-NLS CDC55-MYC
9. ORC6-rxl,ps GAL-CDC6ΔNT MCM7-NLS cdc55-101-MYC

Figure 4.5. cdc55-101 mutation causes synthetic growth defects in pre-RC mutants. Cells of the
indicated genotype were diluted in a 10-fold serial dilution and spotted on glucose or galactose plates.
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DNA content was examined by propidium iodide staining in re-replicating strains
(ORC6-rxl,ps GAL-CDC6DNT and ORC6-rxl,ps GAL-CDC6DNT MCM7-NLS) that had either
CDC55-MYC or cdc55-101-MYC (Figure 4.6, Blue Lines). Both ORC6-rxl,ps GAL-CDC6DNT
and ORC6-rxl,ps GAL-CDC6DNT MCM7-NLS had a high peak of cells with 2C DNA,
suggesting mitotic arrest (Figure 4.6, Left). In contrast, re-replicating strains with cdc55-101MYC showed mitotic arrest bypass compared to cells with CDC55-MYC (Figure 4.6, Blue lines).
Chromatid segregation status was examined in GAL-CDC6 ORC6-rxl cells that had either
CDC55-MYC or cdc55-101-MYC. 41% of galactose-treated GAL-CDC6 ORC6-rxl CDC55-MYC
cells were in mitosis with unsegregated sister chromatids, compared to 5% of GAL-CDC6
ORC6-rxl cdc55-101-MYC cells (Figure 4.7A, yellow bars). Under galactose treatment, GALCDC6 ORC6-rxl CDC55-MYC cells also showed elongated buds, consistent with metaphase
arrest, while GAL-CDC6 ORC6-rxl cdc55-101 cells showed normal morphology (Figure 4.7B).
Taken together, these findings suggest that DNA re-replicating cells with cdc55-101 bypassed
mitotic arrest.
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Figure 4.6. cdc55-101 cells show genetic interactions with DNA re-replicating mutations. Cells
of the indicated genotype were grown asynchronously in raffinose-containing medium. Cells were
collected for propidium iodide staining after two hours with or without galactose. Blue lines highlight
CDC55-MYC and cdc55-101-MYC strains.
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Figure 4.7. cdc55-101 cells bypass mitotic arrest in re-replicating cells. (A) Propidium iodidestained cells from Figure 4.6 were examined by fluorescence microscopy and categorized by budding
and chromatid segregation status. Blue=Unbudded, Orange=Small Budded; Gray=Large bud &
segregated chromatids, Yellow=Large bud & unsegregated chromatids (B) Representative images are
shown.
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PP2ACdc55 has been well-studied for its role in arresting the cell cycle when SAC is
activated (90). Thus, I sought to test if SAC is involved in DNA re-replication response. I
examined chromatid segregation in GAL-CDC6 ORC6-rxl mad2D cells. Both MAD2 and mad2D
cells showed a similar number of cells in mitosis with unsegregated sister chromatids after
galactose-treatment (52% and 41% respectively) suggesting that mitotic arrest in response to
DNA re-replication is independent of SAC (Figure 4.8A). Consistent with this, both MAD2 and
mad2D cells showed elongated buds that are characteristic of metaphase arrest (Figure 4.8B).
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Figure 4.8. Mad2 is not necessary for mitotic arrest in re-replicating cells. (A) Cells of the indicated
genotype were treated as described in Figure 4.2. Samples were stained with propidium iodide and
examined by fluorescence microscopy. (Blue=Unbudded, Orange=Small Budded; Gray=Large bud &
segregated chromatids, Yellow=Large bud & unsegregated chromatids). (B) Representative images are
shown.
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DNA re-replication triggers the Mec1-dependent DNA damage response checkpoint (74,
75). The DNA damage response checkpoint activates Rad52, a repair protein that localizes to
DNA damage sites (221). To test if PP2ACdc55 acts in the DNA damage response checkpoint
during DNA re-replication, I used fluorescently tagged Rad52 strains (RAD52-YFP) to examine
foci formation in re-replicating (ORC6-rxl GAL-CDC6) strains with CDC55-MYC or cdc55-101MYC. The number of cells exhibiting Rad52-YFP foci was similar between re-replicating
CDC55-MYC and cdc55-101-MYC cells (29.5% compared to 30.1%) suggesting that PP2ACdc55
acts independently of the DNA damage pathway during re-replication (Figure 4.9).
Taken together, these findings demonstrate that nuclear PP2ACdc55 arrests the cell cycle in
response to DNA re-replication and acts independently of both the SAC and DNA damage
response pathways.
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Figure 4.9. Rad52 foci formation is not altered by Cdc55 nuclear exclusion. (A) RAD52-YFP cells
of the indicated genotype were grown in raffinose-containing medium, then treated with either glucose
or galactose for 2 hours. Samples were examined by fluorescence microscopy to detect Rad52-YFP
foci. (B) Representative images are shown.
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4.2.3 cdc55-101 cells have more Cdc6 protein in mitosis
The premise that Cdc6 has a replication-independent function during mitosis is supported
by evidence that Cdc6 accumulates during mitosis and that mitotic Cdc6 inhibits M-Cdk1 (76,
86, 87). Cdc6 also engages in a functional interaction with Cdc55, a regulatory subunit of PP2A
that regulates mitotic entry, progression, and exit (89, 145). It is therefore possible that Cdc6’s
mitotic function is in the same pathway as PP2ACdc55.
To test if mitotic Cdc6 levels or phosphorylation status are affected by PP2ACdc55
activity, I examined Cdc6 protein over the course of one cell cycle at 15-minute intervals (Figure
4.10A). In WT cells, Cdc6 protein levels were transiently elevated at t=15 minutes after release
from G1 and subsequently degraded, and was again transiently elevated at t=75 minutes,
consistent with prior reports (76). At t=90 minutes, cdc55-101 showed Cdc6 accumulation
compared to WT cells, suggesting that Cdc6 was stabilized (Figure 4.10A).
To further examine how PP2ACdc55 regulates Cdc6 is during mitosis, WT and cdc55-101
cells were treated with the microtubule destabilizer nocodazole to trigger the SAC (Figure
4.10B). Nocodazole-treated cdc55-101 cells showed a more intense Cdc6 phosphoprotein band
compared to WT cells, suggesting that nuclear PP2ACdc55 promotes Cdc6 dephosphorylation
during mitosis.
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Figure 4.10. Cdc6 accumulates in cdc55-101 in mitosis. (A) CDC5-prA CDC55-MYC (WT) or
CDC6-prA cdc55-101-MYC (cdc55-101) cells were arrested in G1 phase with alpha factor, then
released into YPD media. Samples were collected at the indicated times for western blot analysis.
Alpha factor was added to the cultures at 55 minutes after release. Pgk1 was used as a loading
control. (B) CDC55-MYC CDC6-prA (WT) and cdc55-101-MYC CDC6-prA (cdc55-101) cells were
grown in glucose medium with or without nocodazole. Samples were collected after two hours and
Cdc6 was detected by western blot analysis. Pgk1 is shown as a loading control.
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4.2.4 PP2ACdc55 and S-phase entry
Since Cdc6 is a Pre-RC component that is essential for DNA replication, I considered if a
genetic interaction between Cdc6 and Cdc55 had consequences on DNA replication initiation
(46). To test if PP2ACdc55 nuclear activity affects DNA replication, I monitored DNA content in
synchronized WT and cdc55-101 cells. At t=30 minutes, 41.6% of WT cells were in G1 phase,
compared to 67.9% of cdc55-101 cells (Figure 4.11, Left and Middle). To confirm that the Sphase delay was specifically due to Cdc55 nuclear exclusion, cdc55-101 cells were transformed
with CDC55-containing plasmid (cdc55-101+CDC55) to overexpress Cdc55 (Figure 4.11,
Right). At 30 minutes after release from G1, 53% of cdc55-101+CDC55 cells were in G1 phase,
indicating a partial rescue of the S-phase delay (Figure 4.11). This partial rescue by CDC55
overexpression may indicate that S-phase entry is dependent specifically on nuclear Cdc55, and
therefore an increase in overall Cdc55 protein levels may not have a prominent effect on S-phase
entry. At 40 minutes after G1 release, the cdc55-101+CDC55 cells showed similar cell cycle
profile to WT cells (35.2% of cdc55-101+CDC55 cells in G1 compared to 31.8% of WT cells).
In contrast, 57.9% of cdc55-101 cells were in G1 (Figure 4.11). This time course shows that
cdc55-101 cells undergo a cell cycle delay that correlates with S-phase, but it is not conclusive if
the delay is specific to S-phase or if cdc55-101 cells have a general cell cycle delay.
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Figure 4.11. cdc55-101 cells show an S-phase entry delay. CDC55, cdc55-101, and cdc55-101
cells transformed with a plasmid containing CDC55 (cdc55-101+CDC55) were arrested in G1 by alpha
factor and released. Cells were collected at the indicated time points for propidium iodide staining and
flow cytometry.. Percent of cells in G1 phase is shown.
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Although cdc55-101 cells appeared to show a delay in S-phase entry, it was inconclusive
if the delay was specific to S-phase or if it was a general cell cycle delay. To examine cell cycle
progression rate during a difference stage of the cell cycle, I used cdc20D GAL-CDC20 cells with
either CDC55 or cdc55-101. The cdc20D GAL-CDC20 strain can be reversibly arrested in
metaphase by glucose and released when glucose is removed, as Cdc20 is an APC binding
partner that triggers the metaphase-to-anaphase transition (35). cdc20D GAL-CDC20 cells with
either CDC55 or cdc55-101 were arrested in metaphase using glucose and released. Cell cycle
progression from metaphase was monitored, and there was no significant difference in cell cycle
profile between CDC55 and cdc55-101 (Figure 4.12). This result, taken with findings from the
G1 block-and-release experiment, demonstrate that cdc55-101 cells undergo a S-phase-specific
delay (Figures 4.11- 4.12).
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Figure 4.12. cdc55-101 cells do not show altered cell cycle profile in metaphase. cdc20𝛥 GALCDC20 CDC55 (WT) and cdc20𝛥 GAL-CDC20 cdc55-101 (cdc55-101) cells were grown in raffinosecontaining media, arrested in metaphase by glucose, and released into galactose-containing media.
Samples were taken every 15 minutes for propidium iodide staining and flow cytometry.
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4.3 PP2ACdc55 and Cdc6: Discussion
4.3.1 Cdc55 and Cdc6 engage in a genetic interaction
Findings from this study show a functional relationship between Cdc55 and Cdc6 during
mitosis, but contradict Boronat’s model that proposed a Cdc55-Cdc6 physical interaction (89).
The genetic interaction between Cdc55 and Cdc6 has implications in cell cycle arrest resulting
from DNA re-replication or overexpression of stabilized Cdc6.
DNA re-replication and Cdc6 stabilization both result in cell cycle arrest that is
dependent on nuclear PP2ACdc55. My findings suggest that PP2ACdc55 acts in a pathway that is
distinct from the DNA damage checkpoint and the Mad2-dependent SAC. Boronat et al.
previously proposed a model in which Cdc6 recruits PP2ACdc55 and directs it to deactivate the
APC (89). Although my findings contradict the assertion that Cdc6 and Cdc55 physically
interact, it is still possible that PP2ACdc55 deactivates APC in a Cdc6-dependent manner. In this
scenario, it is still unknown if Cdc6 activates a downstream effector that promotes PP2ACdc55
nuclear activity.
Alternatively, PP2ACdc55 may deactivate APC independently of Cdc6. This would be consistent
with findings presented in Chapter 3 that showed that the APC subunit Cdc16 is
hyperphosphorylated in cdc55-101 in normal cell cycle conditions Thus, nuclear PP2ACdc55 may
deactivate APC through a pathway that is independent of both Cdc6 and SAC.

4.3.2 A role for nuclear PP2ACdc55 in replication origin licensing
My findings suggest that nuclear PP2ACdc55 function is necessary for S-phase entry. There are
multiple pathways in which PP2ACdc55 may act in to promote DNA replication initiation. Since
there is evidence of a genetic interaction between Cdc55 and Cdc6, it is likely that PP2ACdc55
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acts through Cdc6 during S-phase entry. A potential mechanism for PP2ACdc55 regulation of Sphase entry is through regulating the Clb2-Cdc6 interaction that is dependent on a cyclin docking
motif on the Cdc6 N-terminus (87). In this model, Cdc6 N-terminal phosphorylation results in a
Clb2-Cdc6 complex that prevents Cdc6 association with the origin . Nuclear PP2ACdc55 would
reverse Cdc6 N-terminal phosphorylation, thus disrupting the Clb2-Cdc6 interaction and
allowing Cdc6 recruitment to the Pre-RC. In this scenario, Clb2 would be stably bound to Cdc6
in cdc55-101 cells, which may account for the S-phase entry delay.
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Chapter 5: Conclusions
5.1 Cell Cycle Regulation
The findings presented in this study are consistent with the idea that PP2ACdc55’s main
function in cell cycle regulation is to reverse Cdk1-dependent phosphorylation (20). These
results also identify Pds1 as a PP2ACdc55 target. Pds1 phosphorylation by Cdk1 facilitates the
Pds1-Esp1 physical interaction, but whether this complex was also regulated by phosphatase
activity was previously unknown (118). My findings show that PP2ACdc55 dephosphorylates Pds1
during mitosis and that removing nuclear Cdc55 results in enhanced Pds1-Esp1 binding. Results
from this study also provide new insight into Esp1-dependent spindle elongation during anaphase
and show that Pds1 phospho-regulation by Cdk1 and PP2ACdc55 regulate spindle elongation
timing as well as spindle morphology. These results also show that Pds1 phosphorylation status
controls its localization, which elucidates the mechanism of Esp1 nuclear recruitment. In my
proposed model, hyperphosphorylated Pds1 is prematurely localized to the nucleus, where it
forms a tight complex with Esp1, resulting in Esp1 nuclear accumulation (Figure 5.1). The Pds1Esp1 complex is positioned at the SPBs and spindle in metaphase. In this hypothetical model,
Esp1’s protease and spindle elongation functions are separately regulated, and bound Esp1
promotes spindle elongation while leaving cohesin intact.
While PP2ACdc55 has been mostly studied for its role in mitotic regulation, my findings
support an additional role for PP2ACdc55 in S-phase regulation. The mechanism by which nuclear
PP2ACdc55 promotes S-phase entry is most likely through Cdc6 phospho-regulation. Future
directions for this research may focus on whether Cdc6 phosphorylation status affects its
recruitment to the Pre-RC and if a Clb2-Cdc6 physical interaction is regulated to control Pre-RC
formation.
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Figure 5.1. Proposed model of Pds1 phospho-regulation by PP2ACdc55. PP2A
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Cdk1-dependent Pds1 phosphorylation to displace the Pds1-Esp1 complex from the nucleus and
prevent spindle elongation
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5.2 Checkpoint Activity
Prior work examining PP2ACdc55 function showed that it is involved in checkpoint
activity in response to spindle disruption and in morphological defects (90, 91). In line with a
role for PP2ACdc55 in maintaining genome integrity through checkpoint functions, my findings
show that PP2ACdc55 is also involved in the cell cycle’s response to DNA replication stress and
DNA re-replication. Results from this study demonstrate that PP2ACdc55 has multiple functions
during replication stress response that are both Pds1-dependent and -independent. A Pds1dependent mechanism would involve nuclear PP2ACdc55 suppressing spindle elongation by
disrupting the Pds1-Esp1 interaction. The observation that PP2ACdc55 affects spindle elongation
but not cohesin cleavage during replication stress also indicates that Esp1’s two functions are
regulated independently of each other.
My findings suggest that both nuclear and cytoplasmic PP2ACdc55 preserve genomic
integrity during replication stress. The upstream factors controlling PP2ACdc55 during replication
stress are unknown, but my findings suggest that nuclear PP2ACdc55 is either activated by a novel
pathway, or it may be through an uncharacterized branch of the Intra-S checkpoint (Figure 5.2).
Although it is unclear what downstream targets may be regulated by cytoplasmic PP2ACdc55, a
likely candidate is the M-Cdk1 inhibitor Swe1. In contrast to previous research, PP2ACdc55
nuclear exclusion was associated with increased Swe1-dependent M-Cdk1 inhibition, suggesting
that Swe1 is regulated by PP2ACdc55 in the nucleus rather than the cytoplasm. Alternatively,
PP2ACdc55-dependent Swe1 downregulation may be altered during replication stress as part of
checkpoint activity
Additionally, there is evidence that PP2ACdc55 has a novel checkpoint function in DNA
re-replication response that is dependent on Cdc6 but not the DNA damage checkpoint. This
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pathway is likely to act through APC inhibition. Future studies may examine if there is an
upstream effector that activates PP2ACdc55 during DNA re-replication and if the functional
relationship between Cdc6 and Cdc55 is necessary for PP2ACdc55-dependent cell cycle arrest.
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Chapter 6: Materials and Methods
Plasmids and Strains
Standard methods were used for mating, tetrad dissection, and transformation. HA and MYC
tags were generated by PCR method
Table 6.1. Strains used in this study
SKY003
SKY004
SKY005
SKY006
SKY013
SKY015
SKY016
SKY018
SKY019
SKY020
SKY021
SKY022
SKY023

MATa leu2 his3 trp1ade2 GAL4 gal80 LYS2::(lexAop)4HIS3 URA3::(lexAop)s-lacZ
CDC6/pBTM116 + CDC55/pACT
MATa leu2 his3 trp1ade2 GAL4 gal80 LYS2::(lexAop)4HIS3 URA3::(lexAop)s-lacZ
CDC6/pBTM116+ pACT
MATa leu2 his3 trp1ade2 GAL4 gal80 LYS2::(lexAop)4HIS3 URA3::(lexAop)s-lacZ
CDC6(C-terminal domain)/pBTM116 +CDC55/pACT
MATa leu2 his3 trp1ade2 GAL4 gal80 LYS2::(lexAop)4HIS3 URA3::(lexAop)s-lacZ
CDC6 (C-terminal domain)/pBTM116+pACT
MATa ADE2 CDC6-T39A-T368A-prA::His3 his3-11,15
leu2-3,112 trp1-1 ura3-1 can1-100
MATa ADE2 TUB1-GFP-HIS3 PDS1-18xMYC::LEU2
LEU2::GALL-MCK1 his3-11,15 leu2-3,112 trp1-1 ura3-1
can1-100
MATalpha ADE2 TUB1-GFP-HIS3 PDS118xMYC::LEU2 LEU2::GALL-MCK1 his3-11,15 leu23,112 trp1-1 ura3-1 can1-100
MATa bar1 CDC6-prA::HIS3 his3-11,15 leu2-3,112 trp11 ura3-1 can1-100
MATa CDC55-MYC::KanMX URA3::GAL-CDC6T39A,T368A(x10)-HA his3-11,15 leu2-3,112 trp1-1 ura3-1
can1-100
MATalpha CDC55-MYC::KanMX URA3::GAL-CDC6T39A,T368A(x10)-HA his3-11,15 leu2-3,112 trp1-1 ura3-1
can1-100
MATa cdc55-101-MYC::KanMX URA3::GAL-CDC6T39A,T368A(x10)-HA his3-11,15 leu2-3,112 trp1-1 ura3-1
can1-100
MATalpha cdc55-101-MYC::KanMX URA3::GAL-CDC6T39A,T368A(x10)-HA his3-11,15 leu2-3,112 trp1-1 ura3-1
can1-100
MATa ADE2 his3-11,15 leu2-3,112 trp1-1 ura3-1 can1100
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(BCY077)
This study
This study
This study
This study
From F. Cross
RUY508

SKY024
SKY028
SKY029
SKY030
SKY031
SKY032
SKY033
SKY034
SKY037
SKY038
SKY039
SKY040
SKY042

SKY043
SKY044
SKY045
SKY048
SKY049
SKY050

MATa bar1 CDC6-T368A-prA::HIS3 his3-11,15 leu23,112 trp1-1 ura3-1 can1-100
MATa bar1 URA3::GAL-CDC6-T39A, T368A(x10) his311,15 leu2-3,112 trp1-1 ura3-1 can1-100
MATalpha CDC55-MYC::KanMX leu2-3,112 trp1-1 can1100 ura3-1 ade2-1 his3-11,15

This study

MATalpha cdc55-101-MYC::KanMX leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15
MATa CDC6-prA::His cdc55-101-MYC::KanMX leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha CDC6-prA::His cdc55-101-MYC::KanMX
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa CDC6-prA::His CDC55-MYC::KanMX leu2-3,112
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha CDC6-prA::His CDC55-MYC::KanMX leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 URA3::GAL-CDC6-HA ADE2 leu2-3,112
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 URA3::GAL-CDC6-T368A-HA ADE2 leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 URA3::GAL-CDC6DNT-HA ADE2 leu2-3,112
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 URA3::GAL-CDC6DNT-T368A-HA ADE2
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha ADE2::Gal-CDC20 cdc20::Leu CDC6prA::His CDC55-MYC::KanMX leu2-3,112 trp1-1 can1100 ura3-1 ade2-1 his3-11,15

From S. Yoshida

MATalpha Ade::Gal-CDC20 cdc20::Leu CDC6-prA::His
cdc55-101-MYC::KanMX leu2-3,112 trp1-1 can1-100
ura3-1 ade2-1 his3-11,15
MATa Ade::Gal-CDC20 cdc20::Leu CDC6-prA::His
cdc55-101-MYC::KanMX leu2-3,112 trp1-1 can1-100
ura3-1 ade2-1 his3-11,15
MATalpha Ade::Gal-CDC20 cdc20::Leu cdc55-101MYC::KanMX leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1
his3-11,15
MATa cdc4-1 CDC6-prA::HIS3 ADE leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15
MATa cdc4-1 CDC6-prA::HIS3 ADE CDC55MYC::KanMX leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1
his3-11,15
MATa cdc4-1 CDC6-prA::HIS3 ADE cdc55-101MYC::KanMX leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1
his3-11,15

This study
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BCY282
From A. Ikui
BCY568
From A. Ikui
BCY566

SKY051
SKY053
SKY054
SKY055
SKY056
SKY057
SKY058
SKY059
SKY060
SKY061
SKY062
SKY063
SKY064
SKY065
SKY066
SKY067
SKY068
SKY069
SKY070
SKY071
SKY072

MATa ADE::GAL-CDC20 cdc20::LEU CDC55-MYC
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 URA3::GAL-CDC6-T39A, T368A(x10) leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa ORC6-rxl::LEU2 URA3::GAL-CDC6-HA leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa ORC6-rxl::LEU2 URA3::GAL-CDC6 CDC55MYC::KanMX leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1
his3-11,15
MATa ORC6-rxl::LEU2 URA3::GAL-CDC6 cdc55-101MYC::KanMX leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1
his3-11,15
MATalpha mad2::KanMX + pRS413 leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15
MATalpha PDS1-18xMYC::LEU2 leu2-3,112 trp1-1 can1100 ura3-1 ade2-1 his3-11,15
MATa bar1 CDC6-T39A-T368A-prA::HIS3
MATa CDC6-T39A-T368A-prA::HIS3 CDC55MYC::KanMX bar1 leu2-3,112 trp1-1 can1-100 ura3-1
ade2-1 his3-11,15
MATa CDC6-T39A-T368A-prA::HIS3 bar1 leu2-3,112
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa CDC55-MYC::KanMX bar1 leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15
MATalpha cdc55::KanMX URA::GAL-CDC6-T39AT368A leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his311,15
MATa cdc55::KanMX URA::GAL-CDC6-T39A-T368A
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa cdc55::KanMX URA::GAL-CDC6-T39A-T368A
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha URA::GAL-CDC6-T39A-T368A leu2-3,112
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa mad2::KanMX URA::GAL-CDC6-T39A-T368A
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa mad2::KanMX URA::GAL-CDC6-T39A-T368A
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa mad2::KanMX URA::GAL-CDC6-T39A-T368A
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha mad2::KanMX leu2-3,112 trp1-1 can1-100
ura3-1 ade2-1 his3-11,15
MATalpha cdc55::KanMX leu2-3,112 trp1-1 can1-100
ura3-1 ade2-1 his3-11,15
MATalpha ORC6-rxl::LEU URA3::GAL-CDC6 cdc55101-MYC::KanMX RAD52-YFP ADE2 leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15
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This study
From A. Ikui
BCY425
From A. Ikui
BCY426
From A. Ikui
BCY479
From A. Ikui
BCY484
From F. Cross
RUY581
From F. Cross
RUY542
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
From A. Ikui
From A. Ikui
This study

SKY074
SKY076
SKY077
SKY078
SKY079
SKY080
SKY081
SKY086
SKY087
SKY088
SKY089
SKY090
SKY091
SKY096
SKY097
SKY098

MATalpha ORC6-rxl::LEU URA3::GAL-CDC6 CDC55MYC::KanMX RAD52-YFP ADE2 leu2-3,112 trp1-1 can1100 ura3-1 ade2-1 his3-11,15
MATa mad2::KanMX+pRS413 ORC6-rxl::LEU
URA::GAL-CDC6 leu2-3,112 trp1-1 can1-100 ura3-1
ade2-1 his3-11,15
MATalpha mad2::KanMX+pRS413 ORC6-rxl::LEU
URA::GAL-CDC6 leu2-3,112 trp1-1 can1-100 ura3-1
ade2-1 his3-11,15
MATa cdc55:KanMX ORC6-rxl::LEU URA::GAL-CDC6HA leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha cdc55:KanMX ORC6-rxl::LEU URA::GALCDC6-HA leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1
his3-11,15
MATalpha PDS1-18xMYC::LEU2 ORC6-rxl::LEU URAGAL-CDC6-HA leu2-3,112 trp1-1 can1-100 ura3-1 ade21 his3-11,15
MATalpha PDS1-18xMYC::LEU2 ORC6-rxl::LEU URAGAL-CDC6-HA leu2-3,112 trp1-1 can1-100 ura3-1 ade21 his3-11,15
MATalpha PDS1-18xMYC::LEU2 ORC6-rxl::LEU URAGAL-CDC6-HA cdc55-101-MYC::KanMX leu2-3,112
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha PDS1-18xMYC::LEU2 ORC6-rxl::LEU URAGAL-CDC6-HA cdc55-101-MYC::KanMX leu2-3,112
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa RAD52-YFP ADE2 leu2-3,112 trp1-1 can1-100
ura3-1 ade2-1 his3-11,15
MATa ORC6-rxl::LEU URA::GAL-CDC6-HA PDS16HA::TRP bar1 leu2-3,112 trp1-1 can1-100 ura3-1 ade21 his3-11,15
MATa ORC6-rxl::LEU URA::GAL-CDC6-HA PDS16HA::TRP bar1 leu2-3,112 trp1-1 can1-100 ura3-1 ade21 his3-11,15
MATa ORC6-rxl::LEU URA::GAL-CDC6-HA PDS16HA::TRP bar1 leu2-3,112 trp1-1 can1-100 ura3-1 ade21 his3-11,15
MATalpha CDC6-T39A-T368A::HIS ADE2 bar1 leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha CDC6-T39A-T368A::HIS ADE2 bar1 leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa ORC6-rxl::LEU URA::GAL-CDC6-HA PDS16HA::TRP cdc55-101::KanMX bar1 leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15
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This study
From A. Ikui
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

SKY099
SKY105
SKY106
SKY107
SKY116
SKY117
SKY127
SKY128
SKY129
SKY132
SKY133
SKY134
SKY135
SKY143
SKY144
SKY145
SKY146
SKY147
SKY148
SKY149

MATa ORC6-rxl::LEU URA::GAL-CDC6-HA PDS16HA::TRP cdc55-101::KanMX bar1 leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 URA3::GAL-CDC6-T39A, T368A-HA leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 ORC6-rxl::LEU URA::GAL-CDC6-HA PDS16xHA::TRP cdc55-101-MYC::KanMX leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 ORC6-rxl::LEU URA::GAL-CDC6-HA PDS16xHA::TRP cdc55-101-MYC::KanMX leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15
MATalpha ADE2::GAL-CDC20 cdc20::LEU2 leu2-3,112
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha CDC6-GFP::His leu2-3,112 trp1-1 can1-100
ura3-1 ade2-1 his3-11,15
MATa ADE::GAL-CDC20 cdc20::LEU CDC6-GFP::His
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha ADE::GAL-CDC20 cdc20::LEU CDC6GFP::His leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his311,15
MATalpha ADE::GAL-CDC20 cdc20::LEU CDC6GFP::His leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his311,15
MATa CDC6-prA::HIS CDC55-MYC::KanMX bar1 leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa CDC6-prA::HIS cdc55-101-MYC::KanMX bar1
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa cdc55::KanMX leu2-3,112 trp1-1 can1-100 ura3-1
ade2-1 his3-11,15
MATa sml1::HIS3 mec1::trp1::KanMX leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 cdc16-6A-TAP-URA3 leu2-3,112 trp1-1 can1100 ura3-1 ade2-1 his3-11,15
MATa bar1 APC1-TAP-URA3 leu2-3,112 trp1-1 can1-100
ura3-1 ade2-1 his3-11,15
MATa bar1 CDC16-6xMYC-URA3 leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15
MATa APC1-TAP-URA3 cdc16-6A-TRP1 cdc23-A-HYG
cdc27-5A-KAN leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1
his3-11,15
MATa bar1 cdc27-5A-KAN leu2-3,112 trp1-1 can1-100
ura3-1 ade2-1 his3-11,15
MATa bar1 CDC16-TAP-HIS3 leu2-3,112 trp1-1 can1100 ura3-1 ade2-1 his3-11,15
MATa bar1 ADE2 CDC16-6xHA::TRP leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15
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This study
From A. Ikui
BCY418
This study
This study
From F. Cross
RUY518
From A. Ikui
BCY462
This study
This study
This study
This study
This study
This study
RUY321
From A. Rudner3822
From A. Rudner6174
From A. Rudner1951
From A. Rudner6590
From A.Rudner2031
From A. Rudner3089
This study

SKY158
SKY159
SKY160
SKY164
SKY165
SKY166
SKY167
SKY171
SKY172
SKY173
SKY174
SKY175
SKY176
SKY177
SKY178
SKY179
SKY180
SKY181
SKY182
SKY183
SKY184

MATalpha ura3::3xURA3 tetO112, leu2::LEU2 tetR-GFP
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 Cdc55-GFP::His
MATa Pds1-6xHA::TRP Cdc55-MYC::KanMX bar1 leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa Clb5-prA::His
MATalpha Clb5-prA::His Cdc55-MYC::KanMX leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha Clb5-prA::His cdc55-101-MYC::KanMX leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa ADE2 Cdc55-GFP::His leu2-3,112 trp1-1 can1100 ura3-1 ade2-1 his3-11,15
MATa bar1 ADE2 cdc55-101-MYC::KanMX PDS16xHA::TRP
MATa bar1 CDC55-MYC::KanMX Pds1-6xHA::TRP
TUB1-GFP::HIS ADE2 leu2-3,112 trp1-1 can1-100 ura31 ade2-1 his3-11,15
MATa bar1 cdc55-101-MYC::KanMX Pds1-6xHA::TRP
TUB1-GFP::HIS ADE2 leu2-3,112 trp1-1 can1-100 ura31 ade2-1 his3-11,15
MATa pds1::TRP1 bar1::URA3 leu2-3,112 trp1-1 can1100 ura3-1 ade2-1 his3-11,15
MATa swe1::TRP1 bar1::URA3 leu2-3,112 trp1-1 can1100 ura3-1 ade2-1 his3-11,15
MATa rad53::LEU2 sml1 bar1::URA3 leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15
MATalpha mec1:trp1::KanMX CDC55-MYC::KanMX
sml1::HIS leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his311,15
MATalpha mec1:trp1::KanMX cdc55-101-MYC::KanMX
sml1::HIS leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his311,15
MATa cdc55-101-MYC::KanMX sml1::HIS leu2-3,112
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha CDC55-MYC::KanMX mad2::KanMX ADE2
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa cdc55-101-MYC::KanMX mad2::KanMX ADE2
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 cdc55::KanMX PDS1-18xMYC::LEU leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 ADE2 Pds1-6xHA::TRP leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15
MATa CDC55-MYC::KanMX sml1::HIS leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15
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From K. Nasmyth
K6745
Thermo Fisher yeast
GFP collection
This study
From F. Cross
RUY291
This study
This study
This study
This study
This study
This study
From D. Quintana
YRP33
From D. Quintana
YGP98
From D. Quintana
YGP24
This study
This study
This study
This study
This study
This study
This study
This study

SKY185
SKY186
SKY187
SKY188
SKY189
SKY190
SKY191
SKY192
SKY193
SKY194
SKY195
SKY196
SKY197
SKY198
SKY200
SKY204
SKY205
SKY206
SKY207

MATa sml1::HIS leu2-3,112 trp1-1 can1-100 ura3-1 ade21 his3-11,15
MATalpha cdc55::KanMX ADE2 leu2-3,112 trp1-1 can1100 ura3-1 ade2-1 his3-11,15
MATa bar1::URA CDC55-MYC::KanMX rad53::LEU
sml1::HIS leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his311,15
MATa bar1::URA CDC55-MYC::KanMX rad53::LEU
sml1::HIS leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his311,15
MATa bar1::URA cdc55-101-MYC::KanMX rad53::Leu
sml1::HIS leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his311,15
MATa bar1::URA CDC55-MYC::KanMX pds1::TRP leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha bar1::URA CDC55-MYC::KanMX pds1::TRP
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1::URA cdc55-101-MYC::KanMX pds1::TRP
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1::URA cdc55-101-MYC::KanMX swe1::TRP
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1::URA CDC55-MYC::KanMX swe1::TRP
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 cdc55::KanMX Pds1-6xHA::TRP leu2-3,112
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 cdc55::KanMX Pds1-6xHA::TRP leu2-3,112
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 cdc55-101-MYC::KanMX CDC16-6xHA::TRP
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa cdc55::his5+ promURA3::tetR::GFP::LEU2
CenIV::teto×448::URA3 leu2-3,112 trp1-1 can1-100
ura3-1 ade2-1 his3-11,15
MATa esp1-1MCD1-HA6-HIS3URA3-tetO-112 LEU2tetR-GFP leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his311,15
MATa bar1 pds1S277AS292T301A-HA::URA3 leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 pds1-38-HA::URA TUB1-GFP::HIS leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa promURA::tetR::GFP::LEU
CenIV::tetOx448::URA leu2-3,112 trp1-1 can1-100 ura31 ade2-1 his3-11,15
MATalpha promURA::tetR::GFP::LEU
CenIV::tetOx448::URA CDC55-MYC::KanMX leu2-3,112
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
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This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
From Y. Wang (5351-1)
From Y. Wang (66813-2)
From O. Cohen-Fix
(RA2815)
This study
This study
This study

SKY208
SKY209

SKY210

SKY211
SKY212
SKY213
SKY214
SKY216
SKY218
SKY219
SKY220
SKY221
SKY222
SKY223
SKY224
SKY225
SKY226
SKY227
SKY228
SKY229

MATalpha promURA::tetR::GFP::LEU
CenIV::tetOx448::URA cdc55-101-MYC::KanMX leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 CDC55-MYC::KanMX
promURA::tetR::GFP::LEU CenIV::tetOx448::URA
ADE2 leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his311,15
MATa bar1 cdc55-101-MYC::KanMX
promURA::tetR::GFP::LEU CenIV::tetOx448::URA
ADE2 leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his311,15
MATalpha rts1::KanMX leu2-3,112 trp1-1 can1-100 ura31 ade2-1 his3-11,15
MATa bar1 ADE2 ESP1-9xMYC::TRP leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 ADE2 ESP1-9xMYC::TRP leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15
MATa cdc55::Cdc55-GFP-NLS::KanMX leu2-3,112 trp11 can1-100 ura3-1 ade2-1 his3-11,15
MATa cdc55::Cdc55-GFP-NES::KanMX leu2-3,112 trp11 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha ADE2 Pds1-6xHA::TRP leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15
MATalpha rts1::KanMX ADE2 Pds1-6xHA::TRP leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 Pds1-6xHA::TRP cdc55::KanMX leu2-3,112
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 Pds1-6xHA::TRP cdc55::KanMX leu2-3,112
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha rts1::KanMX Pds1-6xHA::TRP leu2-3,112
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha rts1::KanMX Pds1-6xHA::TRP leu2-3,112
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha cdc55::KanMX Pds1-6xHA::TRP ADE2 leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha cdc55::KanMX Pds1-6xHA::TRP ADE2 leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 CDC55-MYC::KanMX pds1-38-HA::URA
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 CDC55-MYC::KanMX pds1-38-HA::URA
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 cdc55-101::KanMX pds1-38-HA::URA leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 cdc55-101-MYC::KanMX pds1-38-HA::URA
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
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This study
This study

This study

This study
This study
This study
From S. Yoshida
SY1808
From S. Yoshida
SY1811
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

SKY230
SKY231
SKY232
SKY233
SKY234
SKY235
SKY236
SKY237
SKY238
SKY239
SKY241
SKY242
SKY244
SKY247
SKY248
SKY250
SKY252
SKY254
SKY255

MATa bar1 rts1::KanMX Pds1-6xHA::TRP leu2-3,112
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1::URA swe1::TRP cdc55:KanMX Pds16xHA::TRP leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1
his3-11,15
MATa bar1::URA swe1::TRP Pds1-6xHA::TRP leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha Pds1-6xHA::TRP Esp1-9xMYC::TRP ADE2
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa cdc55::KanMX Pds1-6xHA::TRP Esp19xMYC::TRP ADE2 leu2-3,112 trp1-1 can1-100 ura3-1
ade2-1 his3-11,15
MATalpha GAL-CDC55-HA::LEU ADE2 leu2-3,112 trp11 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 GAL-CDC55-HA::LEU PDS1-18xMYC::LEU
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha GAL-CDC55-HA::LEU PDS1-18xMYC ADE2
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa GAL-CDC55-HA::LEU PDS1-6xHA::TRP ESP19xMYC::TRP ADE2 leu2-3,112 trp1-1 can1-100 ura3-1
ade2-1 his3-11,15
MATa bar1 PDS1-3xHA::URA leu2-3,112 trp1-1 can1100 ura3-1 ade2-1 his3-11,15
MATa bar1 Pds1-3xHA::URA cdc55-101-MYC::KanMX
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATalpha Pds1-3xHA::URA cdc55-101-MYC::KanMX
MATa bar1::his pds1-5A-3xHA (unmarked) leu2-3,112
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 pds1-5A-3xHA cdc55-101-MYC::KanMX
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 TUB1-GFP::HIS pds1-38-3xHA::URA cdc55101-MYC::KanMX leu2-3,112 trp1-1 can1-100 ura3-1
ade2-1 his3-11,15
MATa bar1 RTS1-9xMYC::TRP ADE2 leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15

This study

MATa GAL1pr-CDC55-PK3::LEU2 (x2) swe1::HIS leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa cdc55-101-MYC::KanMX pds1-38-HA::URA
TUB1-GFP::HIS leu2-3,112 trp1-1 can1-100 ura3-1
ade2-1 his3-11,15
MATalpha cdc55-101::MYC pds1-38-3xHA::URA TUB1GFP::HIS leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1
his3-11,15

This study

145

This study
This study
This study
This study
From J. Philip
JPY019
This study
This study
This study
From O. Cohen-Fix
OCF1522
This study
SK95-2A
From L. HoltLH505
This study
This study
This study

This study
This study

SKY256
SKY257
SKY258
SKY259
SKY260
SKY261
SKY265
SKY266
SKY267
SKY268
SKY269
SKY270
SKY271
SKY272
SKY273
SKY274
SKY275
SKY276
SKY277
SKY278

MATa bar1 cdc55::KanMX PDS1-6xHA::TRP ESP19xMYC::TRP swe1::TRP leu2-3,112 trp1-1 can1-100
ura3-1 ade2-1 his3-11,15
MATa bar1 cdc55::KanMX PDS1-6xHA::TRP ESP19xMYC::TRP swe1::TRP leu2-3,112 trp1-1 can1-100
ura3-1 ade2-1 his3-11,15
MATa bar1 PDS1-6xHA::TRP ESP1-9xMYC::TRP
swe1::TRP leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1
his3-11,15
MATa PDS1-6xHA::TRP ESP1-9xMYC::TRP swe1::TRP
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa cdc55-101-MYC::KanMX ADE2 leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 chk1Δ
MATa bar1 ADE2 chk1::KanMX leu2-3,112 trp1-1 can1100 ura3-1 ade2-1 his3-11,15
MATa bar1 CDC55-MYC::KanMX chk1::KanMX leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 cdc55-101-MYC::KanMX chk1::KanMX leu23,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa esp1::ESP1-GFP-URA
MATa pds1::PDS1-GFP-TRP

This study
This study
This study
This study
This study
From Euroscarf
Deletion Library
This study
This study
This study

From J. Haber BL73
From J. Haber
BL123
MATalpha esp1::ESP1-GFP-URA leu2-3,112 trp1-1 can1- This study
100 ura3-1 ade2-1 his3-11,15
MATalpha esp1::ESP1-GFP-URA cdc55-101This study
MYC::KanMX leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1
his3-11,15
MATalpha esp1::ESP1-GFP-URA leu2-3,112 trp1-1 can1- This study
100 ura3-1 ade2-1 his3-11,15
MATalpha pds1::PDS1-GFP-TRP cdc55-101This study
MYC::KanMX
MATalpha Pds1-6xHA::TRP leu2-3,112 trp1-1 can1-100
This study
ura3-1 ade2-1 his3-11,15
MATalpha cdc55-101-MYC::KanMX ADE2 leu2-3,112
This study
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 esp1::ESP1-GFP::URA ADE2 cdc55-101This study
MYC::KanMX leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1
his3-11,15
MATa bar1 esp1::ESP1-GFP::URA ADE2 leu2-3,112
This study
trp1-1 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 esp1::ESP1-GFP::URA ADE2 cdc55-101This study
MYC::KanMX leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1
his3-11,15
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SKY279
SKY280
SKY282
SKY283

MATa bar1 pds1::PDS1-GFP-TRP ADE2 leu2-3,112 trp11 can1-100 ura3-1 ade2-1 his3-11,15
MATa bar1 pds1::PDS1-GFP-TRP ADE2 cdc55-101MYC::KanMX leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1
his3-11,15
MATa bar1 mih1::KanMX cdc55-101-MYC::KanMX
CDC6-prA::HIS ADE2 leu2-3,112 trp1-1 can1-100 ura3-1
ade2-1 his3-11,15
MATalpha mih1::KanMX cdc55-101-MYC::KanMX ADE2
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15

This study
This study
This study
This study

Table 6.2. Plasmids used in this study
pYM6

6xHA protein tag

pYM3

9xMYC protein tag

pACT

Yeast 2-hybrid

CDC55/pACT

Yeast 2-hybrid

pBTM116

Yeast 2-hybrid

CDC6/pBTM116

Yeast 2-hybrid

pRS425

Yeast plasmid

CDC55/pRS425

Yeast plasmid

Table 6.3. Primers used in this study
Pds1-6HA (pYM3)

S3: 5’CAGCGAAGAAGGCCTCGATCCTGAAGAACTAGA
GGACTTAGTTACTC GTACGCTGCAGGTCGAC 3’; S2:
5’CTGTATATACGTGTATATATGTTGTGTGTATGTG
AATGAGCAGTGGATATCGATGAATTCGAGCTCG 3’)

Esp1-9MYC (pYM6)

S3: 5’GGCGC AGCTCCTGTTATTTATGGGTTACCGATC
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AAGTTCG TATCACGTACGCTGCAGGTCGAC 3’; S2:
5’CAATGCCTATATGAAATCTTTTCGAAAC
AGCCAGTACATGTAACAAATCGATGAATTC
GAGCTC3’
Cdc16-6HA (pYM3)

S3:
5’TAATAATGCCGACGATGGATTTGACGCA
GATATGGAACTGGAACTGGAAGTACGCTGCAGG
TCGAC3’; S2: 5’GTACTAAGTCGTGTCTTTATTCCTCGC
CCGCCTTCGTACTATCGATGAATTCGAGGTCGAC3’

Rts1-9MYC (pYM6)

S3: 5’GAAGAGAACGAAAATGATTGTGACAG
CGAGATACAGCGTACGCTGCAGGTCGAC3’; S2:
5’CCTCACTTCTTCGAGCTTGTAATGAATTG
CTGTATCGATGAATTCGAGCTC3’

Chk1 deletion

5’CAACCTCAACCAAATACTATGTTCC 3’;
5’CTGTGGAAGAAAGAAGAAACTTGAG 3’

Mih1 deletion

5’ TTTGATACATTGTTCCGGCGTTTAAA 3’;
5’AGACTGCATTAGCAAAAGAGCCATT 3’

Cell Culture and Media
Yeast extract peptone media with glucose (YPD) was used for cell culture for western blot, flow
cytometry, and serial dilution experiments. Synthetic Complete (SC) media with glucose was
used for fluorescence microscopy experiments with TUB1-GFP. SC-low fluorescence media
with glucose was used for fluorescence microscopy experiments with CenIV-GFP dots (260).
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Synthetic media without leucine was used for time course experiments with cells containing
pRS425 plasmids. All cell culture was performed at 30°C and 200RPM.

Serial dilutions
For serial dilutions presented in Chapter 3: Cells were grown overnight in 3mL YPD at room
temperature. Cells were diluted 10-fold and 5μl was spotted on YPD plates containing the
indicated concentration of HU. Plates were incubated for 3 days at room temperature.
For serial dilutions presented in Chapter 4: Cells were grown overnight in 3mL YPR at room
temperature. Cells were diluted 10-fold and 5μl were spotted on either YPD or YPG plates.
Plates were incubated for 2 days at 30°C. For experiments using benomyl, plates contained either
the indicated concentration of benomyl or DMSO for control plates.
Flow Cytometry
Cell cycle profiles were monitored by flow cytometry using propidium iodide staining as
previously described (261). Flow cytometry analysis was performed using a BD Accuri C6 flow
cytometer (BD Biosciences, San Jose, CA). 20,000 counts were taken per sample. Results were
analyzed by FlowJo software (FlowJo LLC, Ashland, OR).
Yeast 2-Hybrid Assay
Yeast 2-Hybrid Assay was performed by co-transforming L40 yeast strain with pBTM116 and
pACT plasmids containing sequences of interest. Transformants were patched and transferred to
nitrocellulose. Cells were treated with Z-buffer containing X-gal at 30°C and color changes were
monitored at one-hour intervals.
Western blot, Co-immunoprecipitation and Phos-tag Analysis
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Cells were lysed in TBT Buffer with inhibitors with glass bead agitation as previously described
(80). Proteins were separated using SDS–PAGE with Novex 4–20% Tris-glycine polyacrylamide
gel (Invitrogen, Life Technologies, Carlsbad, CA). Western blot analysis was performed using
peroxide-conjugated anti-hemagglutinin antibody at 1:250 dilution (Roche), anti-cMYC antibody
9E10 (Sigma-Aldrich, St. Louis, MO) at 1:5000 dilution, and anti-Pgk1 (Life Technologies,
Carlsbad, CA) at 1:5000 as a loading control. Images were developed using a Fuji LAS 4000
Imager (GE Healthcare Life Sciences, Pittsburg, PA). Co-immunoprecipitation was performed
by incubating cell lysate with anti-MYC conjugated agarose beads for one hour at 4°C (SigmaAldrich, St. Louis, MO). Phos-tag analysis was performed using phosphoproteins obtained by
TCA precipitation and separated with phos-tag acrylamide gels as previously described (Fujifilm
Wako Pure Chemical, Osaka, Japan) (257, 262, 263).
Microscopy
For all microscopy with the exception of time lapse microscopy, images were obtained with a
Nikon Eclipse 90i fluorescence microscope using a 60×/1.45 numerical aperture Plan
Apochromatic objective lens (Nikon, Tokyo, Japan) with an Intensilight Ultra High Pressure
130-W mercury lamp (Nikon, Tokyo, Japan). Images were taken with a Clara interline chargecoupled device camera (Andor, Belfast, United Kingdom). The images were captured with NISElements software (Nikon, Tokyo, Japan).
Live cell imaging was used for spindle elongation and GFP dot experiments. For spindle
elongation experiments, images were captured using the DIC filter at 80ms exposure and the
FITC filter for 200ms exposure. CenIV and URA GFP dots, Z-stacks were generated with seven
0.5μM steps using the DIC filter at 80ms exposure and FITC filter at 200ms exposure. Images of
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flow cytometry samples using fixed cells were taken using the DIC filter at 80ms exposure time
and the TxRed filter at 50ms exposure. All images were prepared using ImageJ and FIJI software
(NIH, Bethesda, MD) (264).
Time-lapse Microscopy- Performed by Devon Chandler-Brown in Skotheim Lab at
Stanford University
For time lapse microscopy an Observer Z1 (Zeiss, Jena, Germany) microscope equipped with an
automated stage and a plan-apo 63x/1.4NA oil immersion objective. Asynchronous cells were
sonicated at room temperature for five seconds and transferred to 1.5% low-melting agarose pads
made with SC media containing glucose. Live cell imaging was performed over 5 hours with
three minutes per frame. All images were prepared using FIJI software (NIH, Bethesda, MD)
(264).

In vitro phosphatase assay: Performed by Sam Kajjo at Rudner Lab at University of
Ottawa
Pds1-3HA was immunoprecipitated and phosphorylated by Cdc28Clb2 complex to phosphorylate
it. Cdc28Clb2 complex purification was performed as previously described (91, 265). Kinase
reactions were performed with 1 μCi γ-[32P]ATP as previously described (91). Phosphorylated
Pds1-3HA was treated with TAP-purified PP2ACdc55 complexes in vitro as previous described
(91, 129).
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